GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Sp1
|
ENSMUSG00000001280.14 | trans-acting transcription factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Sp1 | mm39_v1_chr15_+_102314809_102314833 | -0.51 | 1.3e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_+_80165787 | 15.55 |
ENSMUST00000105358.8
ENSMUST00000105357.2 ENSMUST00000105354.8 ENSMUST00000105355.8 |
Reep6
|
receptor accessory protein 6 |
chr12_-_84497718 | 14.20 |
ENSMUST00000085192.7
ENSMUST00000220491.2 |
Aldh6a1
|
aldehyde dehydrogenase family 6, subfamily A1 |
chr18_-_38345010 | 13.45 |
ENSMUST00000159405.3
ENSMUST00000160721.8 |
Pcdh1
|
protocadherin 1 |
chr11_+_90140294 | 13.10 |
ENSMUST00000004050.7
|
Mmd
|
monocyte to macrophage differentiation-associated |
chr7_-_16348862 | 12.61 |
ENSMUST00000171937.2
ENSMUST00000075845.11 |
Arhgap35
|
Rho GTPase activating protein 35 |
chr1_+_74371755 | 12.50 |
ENSMUST00000087225.6
|
Pnkd
|
paroxysmal nonkinesiogenic dyskinesia |
chr10_-_88339773 | 12.35 |
ENSMUST00000117579.8
ENSMUST00000073783.6 |
Chpt1
|
choline phosphotransferase 1 |
chr11_+_90140252 | 11.87 |
ENSMUST00000107887.8
|
Mmd
|
monocyte to macrophage differentiation-associated |
chr17_-_57366795 | 11.80 |
ENSMUST00000040280.14
|
Slc25a23
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23 |
chr10_+_80165961 | 11.80 |
ENSMUST00000186864.7
ENSMUST00000040081.7 |
Reep6
|
receptor accessory protein 6 |
chr10_-_88339814 | 11.52 |
ENSMUST00000020253.15
|
Chpt1
|
choline phosphotransferase 1 |
chrX_+_35861851 | 10.80 |
ENSMUST00000073339.7
|
Pgrmc1
|
progesterone receptor membrane component 1 |
chr2_+_58457370 | 10.53 |
ENSMUST00000071543.12
|
Upp2
|
uridine phosphorylase 2 |
chr2_+_155360015 | 9.79 |
ENSMUST00000103142.12
|
Acss2
|
acyl-CoA synthetase short-chain family member 2 |
chr5_+_135015046 | 9.61 |
ENSMUST00000094245.4
|
Cldn3
|
claudin 3 |
chr14_-_52151537 | 9.51 |
ENSMUST00000227402.2
ENSMUST00000227237.2 |
Ndrg2
|
N-myc downstream regulated gene 2 |
chr11_+_94102255 | 9.23 |
ENSMUST00000041589.6
|
Tob1
|
transducer of ErbB-2.1 |
chr2_-_73216743 | 8.99 |
ENSMUST00000112044.8
ENSMUST00000112043.8 ENSMUST00000076463.12 |
Gpr155
|
G protein-coupled receptor 155 |
chr2_+_155359868 | 8.91 |
ENSMUST00000029135.15
ENSMUST00000065973.9 |
Acss2
|
acyl-CoA synthetase short-chain family member 2 |
chr4_-_129142208 | 8.80 |
ENSMUST00000052602.6
|
C77080
|
expressed sequence C77080 |
chr1_+_133291302 | 8.75 |
ENSMUST00000135222.9
|
Etnk2
|
ethanolamine kinase 2 |
chr14_-_20844074 | 8.73 |
ENSMUST00000080440.14
ENSMUST00000100837.11 ENSMUST00000071816.7 |
Camk2g
|
calcium/calmodulin-dependent protein kinase II gamma |
chr5_-_53370761 | 8.69 |
ENSMUST00000031090.8
|
Sel1l3
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
chr4_-_41640321 | 8.66 |
ENSMUST00000127306.2
|
Enho
|
energy homeostasis associated |
chr17_-_45997046 | 8.59 |
ENSMUST00000143907.3
ENSMUST00000127065.8 |
Tmem63b
|
transmembrane protein 63b |
chr10_-_88339935 | 8.53 |
ENSMUST00000117440.8
|
Chpt1
|
choline phosphotransferase 1 |
chr7_-_99276310 | 8.51 |
ENSMUST00000178124.3
|
Tpbgl
|
trophoblast glycoprotein-like |
chrX_-_72759748 | 8.49 |
ENSMUST00000002091.6
|
Bcap31
|
B cell receptor associated protein 31 |
chr14_-_25769457 | 8.47 |
ENSMUST00000069180.8
|
Zcchc24
|
zinc finger, CCHC domain containing 24 |
chr10_-_127456791 | 8.44 |
ENSMUST00000118455.2
ENSMUST00000121829.8 |
Lrp1
|
low density lipoprotein receptor-related protein 1 |
chr4_-_41503046 | 8.41 |
ENSMUST00000054920.5
|
Myorg
|
myogenesis regulating glycosidase (putative) |
chrX_-_84820209 | 8.41 |
ENSMUST00000142152.2
ENSMUST00000156390.8 |
Gk
|
glycerol kinase |
chr17_-_45996899 | 8.27 |
ENSMUST00000145873.8
|
Tmem63b
|
transmembrane protein 63b |
chr9_+_47441471 | 8.23 |
ENSMUST00000114548.8
ENSMUST00000152459.8 ENSMUST00000143026.9 ENSMUST00000085909.9 ENSMUST00000114547.8 ENSMUST00000239368.2 ENSMUST00000214542.2 ENSMUST00000034581.4 |
Cadm1
|
cell adhesion molecule 1 |
chr4_+_117109148 | 8.22 |
ENSMUST00000062824.12
|
Tmem53
|
transmembrane protein 53 |
chr11_+_119833589 | 8.19 |
ENSMUST00000106231.8
ENSMUST00000075180.12 ENSMUST00000103021.10 ENSMUST00000026436.10 ENSMUST00000106233.2 |
Baiap2
|
brain-specific angiogenesis inhibitor 1-associated protein 2 |
chr10_+_128030315 | 8.16 |
ENSMUST00000044776.13
|
Gls2
|
glutaminase 2 (liver, mitochondrial) |
chr18_+_64473091 | 8.14 |
ENSMUST00000175965.10
|
Onecut2
|
one cut domain, family member 2 |
chr4_+_117109204 | 8.06 |
ENSMUST00000125943.8
ENSMUST00000106434.8 |
Tmem53
|
transmembrane protein 53 |
chr4_+_138181616 | 7.92 |
ENSMUST00000050918.4
|
Camk2n1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr15_+_76580925 | 7.91 |
ENSMUST00000023203.6
|
Gpt
|
glutamic pyruvic transaminase, soluble |
chr11_-_70590923 | 7.88 |
ENSMUST00000108543.4
ENSMUST00000108542.8 ENSMUST00000108541.9 ENSMUST00000126114.9 ENSMUST00000073625.8 |
Inca1
|
inhibitor of CDK, cyclin A1 interacting protein 1 |
chr1_+_72863641 | 7.73 |
ENSMUST00000047328.11
|
Igfbp2
|
insulin-like growth factor binding protein 2 |
chr8_+_114860297 | 7.72 |
ENSMUST00000073521.12
ENSMUST00000066514.13 |
Nudt7
|
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
chr1_-_121255753 | 7.53 |
ENSMUST00000003818.14
|
Insig2
|
insulin induced gene 2 |
chr8_+_114860375 | 7.53 |
ENSMUST00000147605.8
ENSMUST00000134593.2 |
Nudt7
|
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
chr15_+_76582372 | 7.48 |
ENSMUST00000229140.2
|
Gpt
|
glutamic pyruvic transaminase, soluble |
chr17_-_45997132 | 7.48 |
ENSMUST00000113523.9
|
Tmem63b
|
transmembrane protein 63b |
chr7_-_19432933 | 7.39 |
ENSMUST00000174355.8
ENSMUST00000172983.8 ENSMUST00000174710.2 ENSMUST00000003066.16 ENSMUST00000174064.9 |
Apoe
|
apolipoprotein E |
chr3_-_89300936 | 7.19 |
ENSMUST00000124783.8
ENSMUST00000126027.8 |
Zbtb7b
|
zinc finger and BTB domain containing 7B |
chr3_-_18297451 | 7.18 |
ENSMUST00000035625.7
|
Cyp7b1
|
cytochrome P450, family 7, subfamily b, polypeptide 1 |
chr16_-_46317135 | 7.17 |
ENSMUST00000149901.2
ENSMUST00000096052.9 |
Nectin3
|
nectin cell adhesion molecule 3 |
chr13_+_12580743 | 7.16 |
ENSMUST00000221560.2
ENSMUST00000071973.8 |
Ero1b
|
endoplasmic reticulum oxidoreductase 1 beta |
chr12_+_8821317 | 7.10 |
ENSMUST00000020911.14
|
Sdc1
|
syndecan 1 |
chr6_+_138117519 | 7.09 |
ENSMUST00000120939.8
ENSMUST00000204628.3 ENSMUST00000140932.2 ENSMUST00000120302.8 |
Mgst1
|
microsomal glutathione S-transferase 1 |
chr12_+_8821404 | 7.07 |
ENSMUST00000171158.8
|
Sdc1
|
syndecan 1 |
chr9_-_110571645 | 7.05 |
ENSMUST00000006005.12
|
Pth1r
|
parathyroid hormone 1 receptor |
chr19_+_4560500 | 7.05 |
ENSMUST00000068004.13
ENSMUST00000224726.3 |
Pcx
|
pyruvate carboxylase |
chrX_-_59449137 | 7.00 |
ENSMUST00000033480.13
ENSMUST00000101527.3 |
Atp11c
|
ATPase, class VI, type 11C |
chr12_+_108300599 | 6.98 |
ENSMUST00000021684.6
|
Cyp46a1
|
cytochrome P450, family 46, subfamily a, polypeptide 1 |
chr7_+_100970435 | 6.97 |
ENSMUST00000210192.2
ENSMUST00000172630.8 |
Stard10
|
START domain containing 10 |
chr4_-_124744454 | 6.96 |
ENSMUST00000125776.8
ENSMUST00000163946.2 ENSMUST00000106190.10 |
1110065P20Rik
|
RIKEN cDNA 1110065P20 gene |
chr9_-_108141105 | 6.93 |
ENSMUST00000166905.8
ENSMUST00000191899.6 |
Dag1
|
dystroglycan 1 |
chr10_+_62860094 | 6.91 |
ENSMUST00000124784.8
|
Pbld2
|
phenazine biosynthesis-like protein domain containing 2 |
chr7_-_19483389 | 6.88 |
ENSMUST00000108450.5
ENSMUST00000075447.14 |
Nectin2
|
nectin cell adhesion molecule 2 |
chr4_-_129132963 | 6.87 |
ENSMUST00000097873.10
|
C77080
|
expressed sequence C77080 |
chrX_-_84820250 | 6.83 |
ENSMUST00000113978.9
|
Gk
|
glycerol kinase |
chr3_-_89300599 | 6.81 |
ENSMUST00000142119.2
ENSMUST00000029677.9 ENSMUST00000148361.8 |
Zbtb7b
|
zinc finger and BTB domain containing 7B |
chr19_+_46120327 | 6.80 |
ENSMUST00000043739.6
ENSMUST00000237098.2 |
Elovl3
|
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 3 |
chr11_+_16702203 | 6.74 |
ENSMUST00000102884.10
ENSMUST00000020329.13 |
Egfr
|
epidermal growth factor receptor |
chr2_-_64853083 | 6.69 |
ENSMUST00000028252.14
|
Grb14
|
growth factor receptor bound protein 14 |
chr10_+_128030500 | 6.62 |
ENSMUST00000123291.2
|
Gls2
|
glutaminase 2 (liver, mitochondrial) |
chr9_-_108140925 | 6.61 |
ENSMUST00000171412.7
ENSMUST00000195429.6 ENSMUST00000080435.9 |
Dag1
|
dystroglycan 1 |
chr2_+_160573604 | 6.61 |
ENSMUST00000174885.2
ENSMUST00000109462.8 |
Plcg1
|
phospholipase C, gamma 1 |
chr9_+_121471782 | 6.59 |
ENSMUST00000035115.5
|
Vipr1
|
vasoactive intestinal peptide receptor 1 |
chr1_-_121255448 | 6.59 |
ENSMUST00000186915.2
ENSMUST00000160968.8 ENSMUST00000162582.2 |
Insig2
|
insulin induced gene 2 |
chr3_+_130411097 | 6.58 |
ENSMUST00000166187.8
ENSMUST00000072271.13 |
Etnppl
|
ethanolamine phosphate phospholyase |
chr14_-_57342150 | 6.56 |
ENSMUST00000055698.8
|
Gjb2
|
gap junction protein, beta 2 |
chr15_+_99192968 | 6.55 |
ENSMUST00000128352.8
ENSMUST00000145482.8 |
Prpf40b
|
pre-mRNA processing factor 40B |
chr2_+_31360219 | 6.54 |
ENSMUST00000102840.5
|
Ass1
|
argininosuccinate synthetase 1 |
chr15_-_85918378 | 6.53 |
ENSMUST00000016172.10
|
Celsr1
|
cadherin, EGF LAG seven-pass G-type receptor 1 |
chr6_+_138117295 | 6.49 |
ENSMUST00000008684.11
|
Mgst1
|
microsomal glutathione S-transferase 1 |
chr17_+_24955647 | 6.47 |
ENSMUST00000101800.7
|
Msrb1
|
methionine sulfoxide reductase B1 |
chr1_-_93406515 | 6.41 |
ENSMUST00000170883.8
ENSMUST00000189025.7 |
Hdlbp
|
high density lipoprotein (HDL) binding protein |
chr8_+_70525546 | 6.41 |
ENSMUST00000110160.9
ENSMUST00000049197.6 |
Tm6sf2
|
transmembrane 6 superfamily member 2 |
chr7_+_100970287 | 6.33 |
ENSMUST00000032927.14
|
Stard10
|
START domain containing 10 |
chr19_+_44977512 | 6.29 |
ENSMUST00000026225.15
|
Sema4g
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G |
chr1_-_121255400 | 6.29 |
ENSMUST00000159085.8
ENSMUST00000159125.2 ENSMUST00000161818.2 |
Insig2
|
insulin induced gene 2 |
chr12_-_104831266 | 6.29 |
ENSMUST00000109937.9
|
Clmn
|
calmin |
chr4_-_124744266 | 6.28 |
ENSMUST00000137769.3
|
1110065P20Rik
|
RIKEN cDNA 1110065P20 gene |
chr16_+_26400454 | 6.27 |
ENSMUST00000096129.9
ENSMUST00000166294.9 ENSMUST00000174202.8 ENSMUST00000023156.13 |
Il1rap
|
interleukin 1 receptor accessory protein |
chr6_-_124894902 | 6.26 |
ENSMUST00000032216.7
|
Ptms
|
parathymosin |
chr19_+_4771089 | 6.25 |
ENSMUST00000238976.3
|
Sptbn2
|
spectrin beta, non-erythrocytic 2 |
chr14_-_20844034 | 6.23 |
ENSMUST00000226630.2
|
Camk2g
|
calcium/calmodulin-dependent protein kinase II gamma |
chr14_-_66361931 | 6.21 |
ENSMUST00000070515.2
|
Ephx2
|
epoxide hydrolase 2, cytoplasmic |
chr14_-_100522101 | 6.21 |
ENSMUST00000228216.2
|
Klf12
|
Kruppel-like factor 12 |
chr10_-_127457001 | 6.20 |
ENSMUST00000049149.15
|
Lrp1
|
low density lipoprotein receptor-related protein 1 |
chr13_+_49340995 | 6.20 |
ENSMUST00000120733.8
|
Ninj1
|
ninjurin 1 |
chr15_-_78687216 | 6.19 |
ENSMUST00000164826.8
|
Card10
|
caspase recruitment domain family, member 10 |
chr11_-_120551426 | 6.18 |
ENSMUST00000106177.8
|
Notum
|
notum palmitoleoyl-protein carboxylesterase |
chr11_-_74816484 | 6.17 |
ENSMUST00000138612.2
ENSMUST00000123855.8 ENSMUST00000128556.8 ENSMUST00000108448.8 ENSMUST00000108447.8 ENSMUST00000065211.9 |
Srr
|
serine racemase |
chr10_+_80003612 | 6.12 |
ENSMUST00000105365.9
|
Cirbp
|
cold inducible RNA binding protein |
chr14_-_52150804 | 6.08 |
ENSMUST00000004673.15
ENSMUST00000111632.5 |
Ndrg2
|
N-myc downstream regulated gene 2 |
chr9_-_118986123 | 6.04 |
ENSMUST00000010795.5
|
Acaa1b
|
acetyl-Coenzyme A acyltransferase 1B |
chr9_-_107544573 | 6.04 |
ENSMUST00000010208.14
ENSMUST00000193932.6 |
Slc38a3
|
solute carrier family 38, member 3 |
chr15_+_85619765 | 6.01 |
ENSMUST00000109423.8
|
Ppara
|
peroxisome proliferator activated receptor alpha |
chr13_-_63036096 | 6.01 |
ENSMUST00000092888.11
|
Fbp1
|
fructose bisphosphatase 1 |
chr12_+_104304631 | 6.00 |
ENSMUST00000043058.5
ENSMUST00000101078.12 |
Serpina3k
Serpina3m
|
serine (or cysteine) peptidase inhibitor, clade A, member 3K serine (or cysteine) peptidase inhibitor, clade A, member 3M |
chr14_-_52151026 | 5.97 |
ENSMUST00000228164.2
|
Ndrg2
|
N-myc downstream regulated gene 2 |
chr11_-_4068779 | 5.97 |
ENSMUST00000003681.8
|
Sec14l2
|
SEC14-like lipid binding 2 |
chr11_-_120551494 | 5.92 |
ENSMUST00000106178.9
|
Notum
|
notum palmitoleoyl-protein carboxylesterase |
chr17_+_24955613 | 5.91 |
ENSMUST00000115262.9
|
Msrb1
|
methionine sulfoxide reductase B1 |
chr5_-_135773047 | 5.88 |
ENSMUST00000153399.2
|
Tmem120a
|
transmembrane protein 120A |
chr11_+_101358990 | 5.87 |
ENSMUST00000001347.7
|
Rnd2
|
Rho family GTPase 2 |
chr5_+_73648368 | 5.83 |
ENSMUST00000113558.8
ENSMUST00000063882.12 |
Dcun1d4
|
DCN1, defective in cullin neddylation 1, domain containing 4 (S. cerevisiae) |
chr15_+_81695615 | 5.79 |
ENSMUST00000023024.8
|
Tef
|
thyrotroph embryonic factor |
chr12_+_103498542 | 5.77 |
ENSMUST00000021631.12
|
Ppp4r4
|
protein phosphatase 4, regulatory subunit 4 |
chr7_+_45354512 | 5.74 |
ENSMUST00000080885.12
ENSMUST00000211513.2 ENSMUST00000211357.2 |
Dbp
|
D site albumin promoter binding protein |
chr2_+_155223728 | 5.69 |
ENSMUST00000043237.14
ENSMUST00000174685.8 |
Trp53inp2
|
transformation related protein 53 inducible nuclear protein 2 |
chr14_+_21102662 | 5.65 |
ENSMUST00000223915.2
|
Adk
|
adenosine kinase |
chr16_-_10884005 | 5.65 |
ENSMUST00000162323.2
|
Litaf
|
LPS-induced TN factor |
chr16_-_17745999 | 5.65 |
ENSMUST00000003622.16
|
Slc25a1
|
solute carrier family 25 (mitochondrial carrier, citrate transporter), member 1 |
chr12_-_104831335 | 5.61 |
ENSMUST00000109936.3
|
Clmn
|
calmin |
chr11_+_54988866 | 5.61 |
ENSMUST00000000608.8
|
Gm2a
|
GM2 ganglioside activator protein |
chr14_+_21102642 | 5.60 |
ENSMUST00000045376.11
|
Adk
|
adenosine kinase |
chr13_-_47196592 | 5.58 |
ENSMUST00000110118.8
|
Tpmt
|
thiopurine methyltransferase |
chr5_-_116560916 | 5.55 |
ENSMUST00000036991.5
|
Hspb8
|
heat shock protein 8 |
chr2_-_26494277 | 5.55 |
ENSMUST00000028286.12
|
Agpat2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta) |
chr11_+_120563844 | 5.54 |
ENSMUST00000106158.9
ENSMUST00000103016.8 ENSMUST00000168714.9 |
Aspscr1
|
alveolar soft part sarcoma chromosome region, candidate 1 (human) |
chr7_-_97228589 | 5.54 |
ENSMUST00000151840.2
ENSMUST00000135998.8 ENSMUST00000144858.8 ENSMUST00000146605.8 ENSMUST00000072725.12 ENSMUST00000138060.3 ENSMUST00000154853.8 ENSMUST00000136757.8 ENSMUST00000124552.3 |
Aamdc
|
adipogenesis associated Mth938 domain containing |
chr4_-_46991842 | 5.52 |
ENSMUST00000107749.4
|
Gabbr2
|
gamma-aminobutyric acid (GABA) B receptor, 2 |
chr14_+_55797934 | 5.50 |
ENSMUST00000121622.8
ENSMUST00000143431.2 ENSMUST00000150481.8 |
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr6_-_119825081 | 5.49 |
ENSMUST00000183703.8
ENSMUST00000183911.8 |
Erc1
|
ELKS/RAB6-interacting/CAST family member 1 |
chr1_-_65218217 | 5.47 |
ENSMUST00000097709.11
|
Idh1
|
isocitrate dehydrogenase 1 (NADP+), soluble |
chr8_-_85526653 | 5.46 |
ENSMUST00000126806.2
ENSMUST00000076715.13 |
Nfix
|
nuclear factor I/X |
chr14_+_55798362 | 5.46 |
ENSMUST00000072530.11
ENSMUST00000128490.9 |
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr7_-_30623592 | 5.45 |
ENSMUST00000217812.2
ENSMUST00000074671.9 |
Hamp2
|
hepcidin antimicrobial peptide 2 |
chr16_-_46317318 | 5.43 |
ENSMUST00000023335.13
ENSMUST00000023334.15 |
Nectin3
|
nectin cell adhesion molecule 3 |
chr15_-_102112159 | 5.41 |
ENSMUST00000229252.2
ENSMUST00000229770.2 |
Csad
|
cysteine sulfinic acid decarboxylase |
chr3_+_118355778 | 5.41 |
ENSMUST00000039177.12
|
Dpyd
|
dihydropyrimidine dehydrogenase |
chr12_-_108241392 | 5.39 |
ENSMUST00000136175.3
|
Ccdc85c
|
coiled-coil domain containing 85C |
chr8_-_105122397 | 5.36 |
ENSMUST00000179802.2
|
Cmtm4
|
CKLF-like MARVEL transmembrane domain containing 4 |
chr12_-_108241597 | 5.35 |
ENSMUST00000222310.2
|
Ccdc85c
|
coiled-coil domain containing 85C |
chr6_-_124391994 | 5.33 |
ENSMUST00000035861.6
ENSMUST00000112532.8 ENSMUST00000080557.12 |
Pex5
|
peroxisomal biogenesis factor 5 |
chr1_-_180845054 | 5.31 |
ENSMUST00000036928.12
ENSMUST00000111068.8 |
Ephx1
|
epoxide hydrolase 1, microsomal |
chr15_-_3612628 | 5.31 |
ENSMUST00000110698.9
|
Ghr
|
growth hormone receptor |
chr11_+_70591299 | 5.30 |
ENSMUST00000152618.9
ENSMUST00000102554.8 ENSMUST00000094499.11 ENSMUST00000072187.12 ENSMUST00000137119.3 |
Kif1c
|
kinesin family member 1C |
chr11_+_114566257 | 5.30 |
ENSMUST00000045779.6
|
Ttyh2
|
tweety family member 2 |
chr5_+_45650716 | 5.29 |
ENSMUST00000046122.11
|
Lap3
|
leucine aminopeptidase 3 |
chr7_+_96981517 | 5.27 |
ENSMUST00000054107.6
|
Kctd21
|
potassium channel tetramerisation domain containing 21 |
chr2_-_147887810 | 5.25 |
ENSMUST00000109964.8
|
Foxa2
|
forkhead box A2 |
chr15_+_25622611 | 5.20 |
ENSMUST00000110457.8
ENSMUST00000137601.8 |
Myo10
|
myosin X |
chr4_-_117992064 | 5.20 |
ENSMUST00000097912.8
ENSMUST00000030263.9 ENSMUST00000106410.8 |
St3gal3
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 3 |
chr7_+_24181416 | 5.18 |
ENSMUST00000068023.8
|
Cadm4
|
cell adhesion molecule 4 |
chr10_-_59452489 | 5.16 |
ENSMUST00000020312.13
|
Mcu
|
mitochondrial calcium uniporter |
chr11_+_98239230 | 5.15 |
ENSMUST00000078694.13
|
Ppp1r1b
|
protein phosphatase 1, regulatory inhibitor subunit 1B |
chr11_-_116089595 | 5.15 |
ENSMUST00000072948.11
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr4_-_107164347 | 5.13 |
ENSMUST00000082426.11
|
Dio1
|
deiodinase, iodothyronine, type I |
chr5_-_120641658 | 5.13 |
ENSMUST00000031597.7
|
Plbd2
|
phospholipase B domain containing 2 |
chr3_-_37473715 | 5.11 |
ENSMUST00000138949.2
ENSMUST00000149449.8 ENSMUST00000108118.9 ENSMUST00000108117.3 ENSMUST00000099130.9 ENSMUST00000052645.13 |
Nudt6
|
nudix (nucleoside diphosphate linked moiety X)-type motif 6 |
chr18_-_60881405 | 5.09 |
ENSMUST00000237070.2
|
Ndst1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
chr6_-_146403410 | 5.08 |
ENSMUST00000053273.15
|
Itpr2
|
inositol 1,4,5-triphosphate receptor 2 |
chr11_-_106503754 | 5.08 |
ENSMUST00000042780.14
|
Tex2
|
testis expressed gene 2 |
chr2_+_27567213 | 5.06 |
ENSMUST00000077257.12
|
Rxra
|
retinoid X receptor alpha |
chr17_+_64907697 | 5.06 |
ENSMUST00000086723.10
|
Man2a1
|
mannosidase 2, alpha 1 |
chr5_+_137568113 | 5.06 |
ENSMUST00000031729.13
ENSMUST00000199054.5 |
Tfr2
|
transferrin receptor 2 |
chr13_+_54937190 | 5.05 |
ENSMUST00000026993.14
ENSMUST00000131692.9 ENSMUST00000163796.8 |
Tspan17
|
tetraspanin 17 |
chrX_-_37545311 | 5.05 |
ENSMUST00000074913.12
ENSMUST00000016678.14 ENSMUST00000061755.9 |
Lamp2
|
lysosomal-associated membrane protein 2 |
chr5_+_31078775 | 5.03 |
ENSMUST00000201621.4
|
Khk
|
ketohexokinase |
chr2_-_130484689 | 5.03 |
ENSMUST00000045761.7
|
Lzts3
|
leucine zipper, putative tumor suppressor family member 3 |
chr11_-_5394838 | 5.02 |
ENSMUST00000109867.8
ENSMUST00000143746.3 |
Znrf3
|
zinc and ring finger 3 |
chr9_+_77661808 | 5.02 |
ENSMUST00000034905.9
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit |
chr13_-_47196633 | 5.00 |
ENSMUST00000021806.11
ENSMUST00000136864.8 |
Tpmt
|
thiopurine methyltransferase |
chr9_+_110075133 | 5.00 |
ENSMUST00000199736.2
|
Cspg5
|
chondroitin sulfate proteoglycan 5 |
chr14_+_55813074 | 4.98 |
ENSMUST00000022826.7
|
Fitm1
|
fat storage-inducing transmembrane protein 1 |
chr2_-_160714473 | 4.98 |
ENSMUST00000103111.9
|
Zhx3
|
zinc fingers and homeoboxes 3 |
chr13_-_35178086 | 4.97 |
ENSMUST00000171258.8
ENSMUST00000170989.8 ENSMUST00000110251.9 ENSMUST00000167036.8 ENSMUST00000171229.8 ENSMUST00000178421.8 ENSMUST00000021854.14 |
Eci2
|
enoyl-Coenzyme A delta isomerase 2 |
chr15_-_76544308 | 4.97 |
ENSMUST00000066677.10
ENSMUST00000177359.2 |
Cyhr1
|
cysteine and histidine rich 1 |
chr17_+_34134873 | 4.97 |
ENSMUST00000172619.8
ENSMUST00000174463.2 |
Tapbp
Zbtb22
|
TAP binding protein zinc finger and BTB domain containing 22 |
chr18_+_84106188 | 4.97 |
ENSMUST00000060223.4
|
Zadh2
|
zinc binding alcohol dehydrogenase, domain containing 2 |
chr13_+_49340961 | 4.96 |
ENSMUST00000049022.15
|
Ninj1
|
ninjurin 1 |
chr10_-_128509764 | 4.95 |
ENSMUST00000054764.9
|
Suox
|
sulfite oxidase |
chr4_+_155648157 | 4.94 |
ENSMUST00000105613.10
|
Nadk
|
NAD kinase |
chr2_-_27317004 | 4.93 |
ENSMUST00000056176.8
|
Vav2
|
vav 2 oncogene |
chr5_+_45650821 | 4.93 |
ENSMUST00000198534.2
|
Lap3
|
leucine aminopeptidase 3 |
chr7_-_19426529 | 4.92 |
ENSMUST00000207978.2
ENSMUST00000108451.4 ENSMUST00000045035.12 |
Apoc1
|
apolipoprotein C-I |
chr1_-_121255503 | 4.92 |
ENSMUST00000160688.2
|
Insig2
|
insulin induced gene 2 |
chr1_+_177270032 | 4.90 |
ENSMUST00000195549.6
|
Zbtb18
|
zinc finger and BTB domain containing 18 |
chr5_-_34345014 | 4.90 |
ENSMUST00000042701.13
ENSMUST00000119171.2 |
Mxd4
|
Max dimerization protein 4 |
chr4_-_107975701 | 4.89 |
ENSMUST00000149106.8
|
Scp2
|
sterol carrier protein 2, liver |
chr1_-_93406091 | 4.89 |
ENSMUST00000188165.2
|
Hdlbp
|
high density lipoprotein (HDL) binding protein |
chr9_-_107586678 | 4.89 |
ENSMUST00000193108.6
|
Sema3f
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr4_+_140966810 | 4.88 |
ENSMUST00000141834.9
|
Arhgef19
|
Rho guanine nucleotide exchange factor (GEF) 19 |
chr1_-_160862364 | 4.87 |
ENSMUST00000177003.2
ENSMUST00000159250.9 ENSMUST00000162226.9 |
Zbtb37
|
zinc finger and BTB domain containing 37 |
chr11_-_74816750 | 4.85 |
ENSMUST00000121738.8
|
Srr
|
serine racemase |
chr1_+_182591425 | 4.83 |
ENSMUST00000155229.7
ENSMUST00000153348.8 |
Susd4
|
sushi domain containing 4 |
chr10_+_75729237 | 4.83 |
ENSMUST00000009236.6
ENSMUST00000217811.2 |
Derl3
|
Der1-like domain family, member 3 |
chr7_-_30752547 | 4.82 |
ENSMUST00000206030.2
|
Fxyd1
|
FXYD domain-containing ion transport regulator 1 |
chr18_+_12776358 | 4.82 |
ENSMUST00000234966.2
ENSMUST00000025294.9 |
Ttc39c
|
tetratricopeptide repeat domain 39C |
chr17_-_56428968 | 4.81 |
ENSMUST00000041357.9
|
Lrg1
|
leucine-rich alpha-2-glycoprotein 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.2 | 24.7 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
5.9 | 17.6 | GO:0021682 | nerve maturation(GO:0021682) |
5.3 | 32.0 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
5.2 | 21.0 | GO:0034031 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
5.1 | 15.4 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
5.1 | 15.3 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
4.7 | 14.1 | GO:0048627 | myoblast development(GO:0048627) |
4.6 | 13.7 | GO:1903000 | regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
4.4 | 13.3 | GO:0006169 | adenosine salvage(GO:0006169) dATP biosynthetic process(GO:0006175) |
4.4 | 17.5 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
4.1 | 12.3 | GO:0019413 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate biosynthetic process(GO:0019542) |
4.0 | 15.9 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
3.9 | 3.9 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
3.7 | 11.2 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
3.6 | 21.7 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
3.5 | 10.5 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
3.5 | 10.4 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
3.4 | 13.7 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
3.4 | 13.6 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
3.2 | 3.2 | GO:0015744 | succinate transport(GO:0015744) |
3.2 | 9.7 | GO:0006867 | asparagine transport(GO:0006867) positive regulation of glutamine transport(GO:2000487) |
3.2 | 12.7 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
3.2 | 9.5 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
3.1 | 12.4 | GO:0030091 | protein repair(GO:0030091) |
3.0 | 15.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
3.0 | 3.0 | GO:1902689 | negative regulation of NAD metabolic process(GO:1902689) negative regulation of glucose catabolic process to lactate via pyruvate(GO:1904024) |
2.9 | 11.8 | GO:0097274 | urea homeostasis(GO:0097274) |
2.9 | 2.9 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
2.8 | 8.5 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
2.6 | 7.9 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
2.6 | 7.8 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
2.6 | 7.8 | GO:1903173 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
2.5 | 7.5 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
2.4 | 9.8 | GO:0032385 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
2.4 | 7.3 | GO:1903537 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
2.4 | 9.6 | GO:0006097 | glyoxylate cycle(GO:0006097) |
2.2 | 11.2 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
2.2 | 6.7 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
2.2 | 9.0 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
2.2 | 11.2 | GO:0045994 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
2.2 | 6.6 | GO:1904766 | negative regulation of macroautophagy by TORC1 signaling(GO:1904766) |
2.2 | 8.9 | GO:0038016 | insulin receptor internalization(GO:0038016) |
2.2 | 6.5 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
2.2 | 15.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
2.1 | 10.5 | GO:0072363 | regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072363) |
2.1 | 6.3 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
2.1 | 21.0 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
2.1 | 10.5 | GO:0070178 | D-serine metabolic process(GO:0070178) |
2.1 | 8.3 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) |
2.1 | 6.2 | GO:1900673 | olefin metabolic process(GO:1900673) |
2.1 | 6.2 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
1.9 | 11.7 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.9 | 1.9 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
1.9 | 7.7 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
1.9 | 9.6 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
1.9 | 5.7 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
1.9 | 7.6 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
1.9 | 7.5 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
1.8 | 16.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
1.8 | 10.9 | GO:0070459 | prolactin secretion(GO:0070459) |
1.8 | 10.8 | GO:0032902 | nerve growth factor production(GO:0032902) |
1.8 | 5.4 | GO:0021998 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
1.8 | 12.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.8 | 8.9 | GO:0015888 | thiamine transport(GO:0015888) |
1.8 | 17.5 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
1.7 | 5.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.7 | 17.2 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
1.7 | 30.8 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
1.7 | 8.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.7 | 5.0 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
1.6 | 11.5 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
1.6 | 8.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.6 | 4.8 | GO:0090420 | naphthalene metabolic process(GO:0018931) naphthalene-containing compound metabolic process(GO:0090420) |
1.6 | 4.8 | GO:0046491 | L-methylmalonyl-CoA metabolic process(GO:0046491) |
1.6 | 17.5 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
1.6 | 6.3 | GO:0034760 | negative regulation of iron ion transport(GO:0034757) negative regulation of iron ion transmembrane transport(GO:0034760) |
1.6 | 4.7 | GO:0001762 | beta-alanine transport(GO:0001762) taurine transport(GO:0015734) |
1.6 | 6.2 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
1.5 | 7.7 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
1.5 | 12.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.5 | 10.6 | GO:0070055 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
1.5 | 6.0 | GO:0050822 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
1.5 | 6.0 | GO:0010046 | response to mycotoxin(GO:0010046) |
1.5 | 1.5 | GO:0061289 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
1.5 | 4.4 | GO:0003167 | atrioventricular bundle cell differentiation(GO:0003167) |
1.5 | 4.4 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.5 | 5.8 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
1.4 | 2.9 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.4 | 4.3 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
1.4 | 5.8 | GO:0080163 | regulation of protein serine/threonine phosphatase activity(GO:0080163) |
1.4 | 1.4 | GO:1901630 | negative regulation of presynaptic membrane organization(GO:1901630) |
1.4 | 7.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
1.4 | 2.9 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
1.4 | 4.3 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
1.4 | 8.5 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
1.4 | 5.6 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
1.4 | 2.8 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
1.4 | 7.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.4 | 4.2 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
1.4 | 8.2 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
1.4 | 4.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.4 | 9.5 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.3 | 16.2 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.3 | 4.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
1.3 | 8.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
1.3 | 9.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.3 | 6.6 | GO:0060431 | primary lung bud formation(GO:0060431) |
1.3 | 10.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
1.3 | 11.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
1.3 | 2.6 | GO:0034226 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
1.3 | 6.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.3 | 24.8 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
1.3 | 14.3 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
1.3 | 5.2 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
1.3 | 1.3 | GO:0060846 | arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
1.3 | 5.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
1.3 | 5.0 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
1.3 | 3.8 | GO:0006530 | asparagine catabolic process(GO:0006530) |
1.3 | 3.8 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
1.3 | 3.8 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
1.2 | 3.7 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
1.2 | 3.7 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
1.2 | 3.6 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
1.2 | 3.6 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.2 | 4.8 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
1.2 | 3.6 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
1.2 | 10.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.2 | 5.9 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
1.2 | 3.5 | GO:0034769 | basement membrane disassembly(GO:0034769) |
1.2 | 3.5 | GO:0006562 | proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
1.2 | 10.6 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
1.2 | 4.7 | GO:0061646 | positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization(GO:0061646) |
1.2 | 8.1 | GO:0051012 | microtubule sliding(GO:0051012) |
1.1 | 6.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.1 | 5.6 | GO:2001185 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
1.1 | 9.0 | GO:0071569 | protein ufmylation(GO:0071569) |
1.1 | 11.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.1 | 5.6 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
1.1 | 3.3 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
1.1 | 2.2 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
1.1 | 6.6 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
1.1 | 6.6 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
1.1 | 3.3 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
1.1 | 3.3 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
1.1 | 4.4 | GO:1904708 | granulosa cell apoptotic process(GO:1904700) regulation of granulosa cell apoptotic process(GO:1904708) |
1.1 | 2.2 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
1.1 | 2.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
1.1 | 3.2 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
1.1 | 3.2 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
1.1 | 3.2 | GO:0072347 | response to anesthetic(GO:0072347) |
1.1 | 31.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
1.1 | 3.2 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
1.1 | 3.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
1.1 | 14.8 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
1.1 | 9.5 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
1.1 | 3.2 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
1.1 | 1.1 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
1.1 | 4.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
1.0 | 6.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
1.0 | 3.1 | GO:0097494 | regulation of vesicle size(GO:0097494) |
1.0 | 1.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.0 | 13.3 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.0 | 4.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
1.0 | 9.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
1.0 | 4.1 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
1.0 | 4.0 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
1.0 | 3.0 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.0 | 3.0 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
1.0 | 5.0 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
1.0 | 11.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.0 | 3.0 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
1.0 | 2.0 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
1.0 | 3.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
1.0 | 2.0 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
1.0 | 2.9 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
1.0 | 2.9 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.0 | 12.7 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
1.0 | 2.9 | GO:1905223 | epicardium morphogenesis(GO:1905223) |
1.0 | 3.9 | GO:0097117 | guanylate kinase-associated protein clustering(GO:0097117) |
1.0 | 2.9 | GO:0021769 | orbitofrontal cortex development(GO:0021769) motogenic signaling involved in postnatal olfactory bulb interneuron migration(GO:0021837) fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development(GO:0035607) positive regulation of mitotic cell cycle DNA replication(GO:1903465) |
1.0 | 5.9 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
1.0 | 4.9 | GO:0014028 | notochord formation(GO:0014028) |
1.0 | 2.9 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
1.0 | 10.6 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
1.0 | 15.4 | GO:1902414 | protein localization to cell junction(GO:1902414) |
1.0 | 4.8 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
1.0 | 2.9 | GO:0071455 | cellular response to hyperoxia(GO:0071455) |
1.0 | 3.8 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.9 | 2.8 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.9 | 2.8 | GO:0033762 | response to glucagon(GO:0033762) |
0.9 | 7.6 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.9 | 0.9 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.9 | 3.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.9 | 14.8 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.9 | 2.8 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
0.9 | 20.4 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.9 | 2.8 | GO:0002396 | MHC protein complex assembly(GO:0002396) peptide antigen assembly with MHC protein complex(GO:0002501) |
0.9 | 3.7 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.9 | 4.6 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.9 | 1.8 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.9 | 5.5 | GO:1903179 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
0.9 | 4.5 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.9 | 5.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.9 | 6.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.9 | 4.5 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.9 | 3.6 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.9 | 2.7 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
0.9 | 4.5 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.9 | 2.7 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.9 | 0.9 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.9 | 1.8 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.9 | 8.0 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.9 | 0.9 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.9 | 3.5 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.9 | 2.6 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.9 | 7.8 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.9 | 6.1 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.9 | 2.6 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.9 | 0.9 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
0.9 | 0.9 | GO:0072003 | kidney rudiment formation(GO:0072003) |
0.9 | 5.1 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.9 | 0.9 | GO:0072197 | ureter morphogenesis(GO:0072197) |
0.8 | 20.4 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.8 | 12.7 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.8 | 3.4 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.8 | 16.9 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.8 | 1.7 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.8 | 5.0 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.8 | 2.5 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.8 | 7.5 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.8 | 2.5 | GO:0090298 | negative regulation of mitochondrial DNA replication(GO:0090298) |
0.8 | 4.1 | GO:1902163 | negative regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902163) |
0.8 | 1.7 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.8 | 4.1 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.8 | 1.6 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.8 | 4.1 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.8 | 15.4 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.8 | 1.6 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
0.8 | 1.6 | GO:0021586 | pons maturation(GO:0021586) |
0.8 | 1.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.8 | 6.4 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.8 | 4.8 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.8 | 4.0 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.8 | 4.0 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.8 | 1.6 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.8 | 2.4 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.8 | 3.2 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.8 | 5.5 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.8 | 0.8 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.8 | 2.4 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.8 | 3.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.8 | 2.4 | GO:1903920 | positive regulation of actin filament severing(GO:1903920) |
0.8 | 2.3 | GO:0015881 | creatine transport(GO:0015881) |
0.8 | 2.3 | GO:0019405 | alditol catabolic process(GO:0019405) |
0.8 | 4.7 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.8 | 1.6 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.8 | 1.6 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.8 | 5.4 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.8 | 1.6 | GO:1904582 | positive regulation of intracellular mRNA localization(GO:1904582) |
0.8 | 7.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.8 | 3.9 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.8 | 3.1 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.8 | 11.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.8 | 4.6 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.8 | 3.1 | GO:0097298 | regulation of nucleus size(GO:0097298) |
0.8 | 2.3 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.8 | 2.3 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.8 | 2.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.8 | 6.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.8 | 9.9 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.8 | 0.8 | GO:0072554 | blood vessel lumenization(GO:0072554) |
0.8 | 5.3 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.8 | 1.5 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.7 | 3.7 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.7 | 3.7 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.7 | 3.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.7 | 2.2 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.7 | 3.7 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.7 | 4.4 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.7 | 0.7 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
0.7 | 6.6 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.7 | 2.2 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.7 | 2.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.7 | 2.9 | GO:0046725 | negative regulation by virus of viral protein levels in host cell(GO:0046725) |
0.7 | 0.7 | GO:0034092 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
0.7 | 2.9 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.7 | 2.2 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.7 | 2.9 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.7 | 2.9 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.7 | 3.6 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.7 | 5.0 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.7 | 6.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.7 | 0.7 | GO:0055093 | response to hyperoxia(GO:0055093) |
0.7 | 2.1 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
0.7 | 2.1 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.7 | 2.1 | GO:0046203 | spermidine catabolic process(GO:0046203) |
0.7 | 21.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.7 | 5.6 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.7 | 2.8 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.7 | 1.4 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
0.7 | 4.2 | GO:1990839 | response to endothelin(GO:1990839) |
0.7 | 2.8 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.7 | 0.7 | GO:0021589 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.7 | 0.7 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.7 | 2.8 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.7 | 7.7 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.7 | 3.5 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.7 | 9.0 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.7 | 0.7 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.7 | 8.3 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.7 | 9.0 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.7 | 2.7 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.7 | 7.5 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.7 | 6.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.7 | 29.9 | GO:0019835 | cytolysis(GO:0019835) |
0.7 | 4.7 | GO:0090383 | phagosome acidification(GO:0090383) |
0.7 | 1.3 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
0.7 | 8.1 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.7 | 8.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.7 | 4.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.7 | 9.4 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.7 | 3.3 | GO:0071332 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.7 | 2.7 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.7 | 2.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.7 | 0.7 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.7 | 2.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.7 | 2.0 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.7 | 2.6 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.7 | 2.0 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.7 | 5.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.7 | 1.3 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.7 | 0.7 | GO:0010159 | specification of organ position(GO:0010159) |
0.7 | 4.6 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.7 | 2.0 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.6 | 16.2 | GO:0002076 | osteoblast development(GO:0002076) |
0.6 | 1.9 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.6 | 2.6 | GO:1904453 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.6 | 5.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.6 | 3.9 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.6 | 1.3 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.6 | 8.9 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.6 | 8.9 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.6 | 5.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.6 | 2.5 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.6 | 6.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.6 | 1.2 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.6 | 1.9 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.6 | 2.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.6 | 3.1 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.6 | 1.9 | GO:0030974 | thiamine pyrophosphate transport(GO:0030974) |
0.6 | 0.6 | GO:0072300 | regulation of metanephric glomerulus development(GO:0072298) positive regulation of metanephric glomerulus development(GO:0072300) |
0.6 | 4.3 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.6 | 1.8 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.6 | 1.8 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.6 | 0.6 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.6 | 2.4 | GO:2000983 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
0.6 | 3.6 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.6 | 1.2 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.6 | 3.6 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.6 | 13.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.6 | 0.6 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.6 | 4.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.6 | 1.8 | GO:0048840 | otolith development(GO:0048840) |
0.6 | 3.0 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.6 | 2.4 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
0.6 | 3.0 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
0.6 | 1.2 | GO:1903978 | regulation of microglial cell activation(GO:1903978) |
0.6 | 2.4 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.6 | 1.8 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.6 | 0.6 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
0.6 | 3.5 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.6 | 5.3 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.6 | 1.8 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.6 | 14.6 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.6 | 2.9 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.6 | 9.9 | GO:0016264 | gap junction assembly(GO:0016264) |
0.6 | 1.7 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.6 | 8.0 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.6 | 1.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.6 | 4.0 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.6 | 1.7 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.6 | 2.3 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.6 | 1.7 | GO:0060596 | mammary placode formation(GO:0060596) |
0.6 | 6.8 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.6 | 1.7 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.6 | 18.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.6 | 9.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.6 | 4.0 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.6 | 14.7 | GO:0060539 | diaphragm development(GO:0060539) |
0.6 | 6.2 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.6 | 5.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.6 | 6.7 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.6 | 3.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.6 | 1.1 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.6 | 2.8 | GO:0006548 | histidine catabolic process(GO:0006548) |
0.6 | 3.9 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.6 | 2.8 | GO:0003383 | apical constriction(GO:0003383) |
0.6 | 4.4 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.6 | 5.0 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.6 | 1.7 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.6 | 3.3 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.6 | 7.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.5 | 3.3 | GO:0060179 | male mating behavior(GO:0060179) |
0.5 | 2.7 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.5 | 0.5 | GO:0035332 | positive regulation of hippo signaling(GO:0035332) |
0.5 | 0.5 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.5 | 2.2 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.5 | 3.3 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.5 | 3.8 | GO:0021548 | pons development(GO:0021548) |
0.5 | 7.0 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.5 | 2.7 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.5 | 1.6 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.5 | 14.5 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.5 | 3.2 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.5 | 6.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.5 | 3.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.5 | 3.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.5 | 5.8 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.5 | 6.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.5 | 2.6 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.5 | 1.6 | GO:2000847 | negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.5 | 3.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.5 | 10.0 | GO:0000338 | protein deneddylation(GO:0000338) |
0.5 | 3.7 | GO:0090005 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.5 | 7.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.5 | 2.1 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
0.5 | 1.0 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.5 | 1.6 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.5 | 1.6 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
0.5 | 4.2 | GO:0034214 | protein hexamerization(GO:0034214) |
0.5 | 4.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.5 | 1.0 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.5 | 2.6 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.5 | 4.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.5 | 1.5 | GO:0040040 | thermosensory behavior(GO:0040040) |
0.5 | 2.0 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.5 | 10.7 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.5 | 1.5 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.5 | 27.7 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.5 | 1.5 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.5 | 2.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.5 | 4.0 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.5 | 0.5 | GO:1900150 | regulation of defense response to fungus(GO:1900150) |
0.5 | 9.0 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.5 | 15.0 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.5 | 1.5 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.5 | 2.5 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.5 | 1.0 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.5 | 6.0 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.5 | 1.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.5 | 2.0 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.5 | 3.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.5 | 4.0 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.5 | 4.4 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.5 | 1.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.5 | 7.4 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.5 | 2.0 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.5 | 6.8 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.5 | 0.5 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.5 | 0.5 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.5 | 1.5 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
0.5 | 6.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.5 | 5.8 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.5 | 1.4 | GO:0003360 | brainstem development(GO:0003360) |
0.5 | 1.9 | GO:0036166 | phenotypic switching(GO:0036166) cellular response to cocaine(GO:0071314) |
0.5 | 2.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.5 | 1.4 | GO:0007314 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
0.5 | 3.8 | GO:0045176 | apical protein localization(GO:0045176) |
0.5 | 35.9 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.5 | 0.5 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
0.5 | 1.0 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.5 | 8.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.5 | 5.2 | GO:0030242 | pexophagy(GO:0030242) |
0.5 | 2.4 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.5 | 5.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.5 | 1.9 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.5 | 8.0 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.5 | 0.9 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.5 | 9.7 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.5 | 1.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.5 | 21.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.5 | 0.9 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.5 | 6.0 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.5 | 0.9 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
0.5 | 0.9 | GO:2000347 | positive regulation of hepatocyte proliferation(GO:2000347) |
0.5 | 11.0 | GO:0099563 | modification of synaptic structure(GO:0099563) |
0.5 | 1.4 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.5 | 1.8 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
0.5 | 5.5 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.5 | 1.8 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.5 | 2.7 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.5 | 1.4 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.4 | 0.9 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.4 | 1.3 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.4 | 1.3 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.4 | 2.7 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.4 | 4.0 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.4 | 7.5 | GO:0072350 | citrate metabolic process(GO:0006101) tricarboxylic acid metabolic process(GO:0072350) |
0.4 | 1.8 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.4 | 1.8 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.4 | 0.4 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.4 | 1.8 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.4 | 3.9 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.4 | 0.4 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.4 | 1.3 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.4 | 0.9 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.4 | 9.9 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.4 | 3.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.4 | 0.4 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) regulation of relaxation of smooth muscle(GO:1901080) positive regulation of relaxation of smooth muscle(GO:1901082) |
0.4 | 0.4 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.4 | 1.7 | GO:0060430 | lung saccule development(GO:0060430) |
0.4 | 1.7 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.4 | 7.2 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.4 | 0.4 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.4 | 5.0 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) |
0.4 | 0.8 | GO:2000469 | negative regulation of peroxidase activity(GO:2000469) |
0.4 | 0.8 | GO:0052805 | imidazole-containing compound catabolic process(GO:0052805) |
0.4 | 5.4 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.4 | 2.9 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.4 | 0.8 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.4 | 2.1 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.4 | 0.4 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
0.4 | 0.8 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.4 | 3.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.4 | 1.2 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.4 | 0.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.4 | 0.4 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
0.4 | 0.8 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.4 | 1.6 | GO:0070384 | Harderian gland development(GO:0070384) |
0.4 | 5.6 | GO:0003334 | keratinocyte development(GO:0003334) |
0.4 | 0.8 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.4 | 8.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.4 | 7.6 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.4 | 1.2 | GO:0046959 | habituation(GO:0046959) |
0.4 | 3.6 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.4 | 0.4 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.4 | 1.2 | GO:0072014 | proximal tubule development(GO:0072014) |
0.4 | 1.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.4 | 2.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.4 | 1.2 | GO:0009188 | ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.4 | 3.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 2.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.4 | 2.3 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.4 | 1.2 | GO:1903699 | tarsal gland development(GO:1903699) |
0.4 | 3.9 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
0.4 | 0.8 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.4 | 11.1 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.4 | 1.9 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.4 | 0.8 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.4 | 1.5 | GO:0006983 | ER overload response(GO:0006983) |
0.4 | 1.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.4 | 3.0 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
0.4 | 1.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 0.8 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.4 | 12.4 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.4 | 1.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.4 | 0.8 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.4 | 1.1 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.4 | 3.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.4 | 0.4 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.4 | 8.6 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.4 | 2.6 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.4 | 3.7 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.4 | 1.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.4 | 0.4 | GO:2000451 | positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) |
0.4 | 1.1 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.4 | 2.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.4 | 0.4 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.4 | 2.2 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.4 | 3.7 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.4 | 1.8 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.4 | 1.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.4 | 0.7 | GO:0015817 | histidine transport(GO:0015817) |
0.4 | 4.0 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.4 | 0.7 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.4 | 0.7 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.4 | 1.5 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.4 | 1.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.4 | 1.1 | GO:0019043 | establishment of viral latency(GO:0019043) |
0.4 | 1.1 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.4 | 0.7 | GO:0072069 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
0.4 | 0.7 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.4 | 0.7 | GO:0015755 | fructose transport(GO:0015755) |
0.4 | 0.4 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.4 | 0.7 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.4 | 9.3 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.4 | 0.4 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.4 | 0.7 | GO:2000556 | regulation of T-helper 1 cell cytokine production(GO:2000554) positive regulation of T-helper 1 cell cytokine production(GO:2000556) |
0.4 | 2.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.4 | 2.8 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.4 | 2.8 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.4 | 6.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.4 | 2.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.4 | 3.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.3 | 15.0 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.3 | 1.7 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.3 | 5.9 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.3 | 1.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.3 | 0.3 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.3 | 1.7 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.3 | 5.5 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.3 | 1.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.3 | 1.0 | GO:0021740 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) |
0.3 | 0.3 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.3 | 1.7 | GO:0072189 | ureter development(GO:0072189) |
0.3 | 2.7 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.3 | 4.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.3 | 1.7 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.3 | 1.0 | GO:0003166 | bundle of His development(GO:0003166) |
0.3 | 1.0 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.3 | 3.0 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.3 | 1.7 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.3 | 2.0 | GO:0006531 | aspartate metabolic process(GO:0006531) |
0.3 | 0.7 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.3 | 1.0 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.3 | 13.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.3 | 1.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 1.6 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.3 | 1.0 | GO:2000536 | negative regulation of entry of bacterium into host cell(GO:2000536) |
0.3 | 1.9 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.3 | 1.3 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.3 | 2.3 | GO:0060309 | elastin catabolic process(GO:0060309) |
0.3 | 2.9 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.3 | 1.3 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.3 | 1.0 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.3 | 1.6 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 0.3 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.3 | 3.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.3 | 1.6 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.3 | 3.8 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.3 | 1.3 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.3 | 0.6 | GO:1903413 | response to bile acid(GO:1903412) cellular response to bile acid(GO:1903413) |
0.3 | 2.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.3 | 2.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 0.9 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.3 | 3.1 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.3 | 0.9 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.3 | 4.3 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.3 | 0.6 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 0.6 | GO:0061439 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
0.3 | 2.1 | GO:0061709 | reticulophagy(GO:0061709) |
0.3 | 0.9 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.3 | 0.9 | GO:0035627 | ceramide transport(GO:0035627) |
0.3 | 5.4 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.3 | 1.2 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.3 | 1.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.3 | 0.9 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.3 | 0.6 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.3 | 0.9 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.3 | 2.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.3 | 0.6 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.3 | 0.6 | GO:0006788 | heme oxidation(GO:0006788) |
0.3 | 0.9 | GO:0006218 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
0.3 | 2.0 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.3 | 1.4 | GO:0021564 | vagus nerve development(GO:0021564) |
0.3 | 0.3 | GO:0034201 | response to oleic acid(GO:0034201) |
0.3 | 1.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.3 | 0.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 0.9 | GO:0042262 | DNA protection(GO:0042262) |
0.3 | 0.3 | GO:0015801 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.3 | 3.7 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.3 | 1.4 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
0.3 | 0.3 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.3 | 1.4 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.3 | 0.8 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.3 | 1.4 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.3 | 1.4 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.3 | 0.6 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.3 | 7.3 | GO:0071625 | vocalization behavior(GO:0071625) |
0.3 | 0.8 | GO:0098734 | protein depalmitoylation(GO:0002084) lipoprotein catabolic process(GO:0042159) macromolecule depalmitoylation(GO:0098734) |
0.3 | 2.5 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 0.3 | GO:0099541 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.3 | 0.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.3 | 0.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.3 | 1.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.3 | 12.4 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 4.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.3 | 2.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.3 | 0.5 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.3 | 1.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.3 | 0.3 | GO:0090264 | immune complex clearance by monocytes and macrophages(GO:0002436) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) |
0.3 | 1.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.3 | 6.9 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.3 | 1.1 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.3 | 2.7 | GO:0051665 | membrane raft localization(GO:0051665) |
0.3 | 1.6 | GO:2000322 | regulation of glucocorticoid receptor signaling pathway(GO:2000322) |
0.3 | 1.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 0.5 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.3 | 2.4 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 0.8 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.3 | 0.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 1.3 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.3 | 3.7 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.3 | 1.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.3 | 1.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.3 | 1.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.3 | 1.5 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.3 | 1.5 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.3 | 3.6 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.3 | 2.0 | GO:0097421 | liver regeneration(GO:0097421) |
0.3 | 1.0 | GO:2000656 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
0.3 | 1.3 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.3 | 0.5 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.3 | 11.1 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 0.8 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.3 | 1.3 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 0.7 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 5.7 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 0.7 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.2 | 3.0 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.2 | 0.5 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.2 | 0.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 1.0 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.2 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 6.6 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 0.2 | GO:0051884 | regulation of anagen(GO:0051884) |
0.2 | 3.6 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 0.2 | GO:0061193 | taste bud development(GO:0061193) |
0.2 | 0.5 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 1.0 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.2 | 0.7 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) mitochondrial tRNA 3'-end processing(GO:1990180) |
0.2 | 0.7 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.2 | 2.4 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
0.2 | 1.0 | GO:0008355 | olfactory learning(GO:0008355) |
0.2 | 1.7 | GO:0015862 | uridine transport(GO:0015862) |
0.2 | 0.2 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.2 | 1.4 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.2 | 1.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 1.4 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.2 | 0.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 1.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 0.2 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.2 | 0.7 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.2 | 1.1 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.2 | 1.6 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 0.5 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.2 | 0.7 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 3.4 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.2 | 1.4 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.2 | 0.7 | GO:0045358 | negative regulation of interferon-beta biosynthetic process(GO:0045358) |
0.2 | 0.7 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.2 | 0.4 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.2 | 4.3 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.2 | 0.7 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
0.2 | 0.7 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.2 | 2.2 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 0.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 3.8 | GO:0022038 | corpus callosum development(GO:0022038) |
0.2 | 0.2 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.2 | 1.8 | GO:0060602 | branch elongation of an epithelium(GO:0060602) |
0.2 | 0.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 1.7 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 1.5 | GO:0007527 | adult somatic muscle development(GO:0007527) |
0.2 | 1.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 3.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.2 | 0.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 1.7 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 0.2 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 0.6 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.2 | 2.6 | GO:0048665 | neuron fate specification(GO:0048665) |
0.2 | 1.5 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 4.6 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 0.8 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.2 | 2.3 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 1.0 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.2 | 0.6 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.2 | 2.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 4.8 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.2 | 2.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 1.0 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 0.8 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.2 | 0.6 | GO:0097475 | motor neuron migration(GO:0097475) |
0.2 | 0.4 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.2 | 0.6 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.2 | 0.6 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
0.2 | 0.2 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.2 | 0.2 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.2 | 0.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 1.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 1.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 1.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 3.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.2 | 0.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 1.2 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.2 | 1.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 1.0 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 2.0 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.2 | 2.4 | GO:0097186 | amelogenesis(GO:0097186) |
0.2 | 2.4 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.2 | 5.2 | GO:0007041 | lysosomal transport(GO:0007041) |
0.2 | 0.4 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 0.8 | GO:0031223 | auditory behavior(GO:0031223) |
0.2 | 1.6 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.2 | 1.8 | GO:0010225 | response to UV-C(GO:0010225) |
0.2 | 0.8 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.2 | 0.8 | GO:0042335 | cuticle development(GO:0042335) |
0.2 | 1.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 11.4 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 8.8 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.2 | 1.5 | GO:0060736 | prostate gland growth(GO:0060736) |
0.2 | 1.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 1.5 | GO:0033131 | regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
0.2 | 1.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 3.0 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 1.1 | GO:1903540 | neurotransmitter receptor transport to plasma membrane(GO:0098877) neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
0.2 | 0.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.2 | 1.7 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.2 | 1.9 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.2 | 0.8 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.2 | 1.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.2 | 1.3 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.2 | 0.4 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.2 | 6.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.2 | 0.6 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 0.2 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.2 | 2.6 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.2 | 1.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.9 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.2 | 1.6 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.2 | 0.5 | GO:1904092 | regulation of autophagic cell death(GO:1904092) negative regulation of autophagic cell death(GO:1904093) |
0.2 | 0.9 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 6.5 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
0.2 | 2.0 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 0.4 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.2 | 0.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 0.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 2.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 6.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.7 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 3.4 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.2 | 1.2 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.2 | 1.1 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.2 | 0.9 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 0.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 0.2 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
0.2 | 0.2 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.2 | 1.7 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 2.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 1.5 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 0.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 1.9 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 0.2 | GO:0070836 | caveola assembly(GO:0070836) |
0.2 | 0.3 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.2 | 0.5 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.2 | 1.0 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.2 | 0.5 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.2 | 1.5 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 1.8 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.2 | 1.9 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.2 | 1.5 | GO:0015961 | diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate catabolic process(GO:0015961) |
0.2 | 0.5 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.2 | 1.1 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
0.2 | 0.6 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
0.2 | 0.3 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.2 | 0.8 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.2 | 0.6 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.2 | 0.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.2 | 2.9 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.2 | 1.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 1.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.2 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.2 | 0.6 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.2 | 0.6 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.2 | 1.3 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.2 | 0.5 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.2 | 2.0 | GO:0070986 | left/right axis specification(GO:0070986) |
0.2 | 0.3 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) |
0.2 | 0.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.2 | 0.8 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.2 | 1.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.2 | 0.9 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.2 | 0.8 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 1.5 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 1.8 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.1 | 1.3 | GO:0036296 | response to increased oxygen levels(GO:0036296) |
0.1 | 2.5 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.4 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 1.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.4 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 1.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.7 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.1 | 2.9 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 1.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.9 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) |
0.1 | 0.6 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.3 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.1 | 1.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.6 | GO:0090282 | positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
0.1 | 3.1 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.1 | 2.3 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.4 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.3 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
0.1 | 0.6 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 1.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 1.1 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 0.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.5 | GO:0070781 | protein biotinylation(GO:0009305) response to biotin(GO:0070781) histone biotinylation(GO:0071110) |
0.1 | 2.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 1.6 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.9 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.3 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.1 | 0.3 | GO:0051695 | actin filament uncapping(GO:0051695) negative regulation of barbed-end actin filament capping(GO:2000813) |
0.1 | 2.3 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.1 | 0.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.7 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.5 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.1 | 2.1 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.5 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.4 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
0.1 | 1.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.6 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 1.0 | GO:0051096 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.1 | 0.4 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 3.5 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.1 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 1.3 | GO:0034312 | diol biosynthetic process(GO:0034312) |
0.1 | 2.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 1.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 1.9 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.4 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.4 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.1 | 1.4 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 1.6 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 1.5 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 1.0 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.1 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) |
0.1 | 0.4 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.1 | 0.4 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 3.9 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.5 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.6 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.3 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.3 | GO:0042196 | chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
0.1 | 2.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.1 | 0.2 | GO:0071865 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.1 | 1.6 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.2 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.1 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
0.1 | 1.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 6.9 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 1.1 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 3.0 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.2 | GO:0044793 | negative regulation by host of viral process(GO:0044793) negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.9 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.8 | GO:1903543 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.1 | 0.1 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
0.1 | 0.2 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 10.5 | GO:0007601 | visual perception(GO:0007601) |
0.1 | 0.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.1 | GO:1901166 | neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.1 | 4.6 | GO:0045661 | regulation of myoblast differentiation(GO:0045661) |
0.1 | 0.3 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.7 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.1 | 5.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 2.0 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.1 | 0.2 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.1 | 0.1 | GO:0046958 | nonassociative learning(GO:0046958) |
0.1 | 1.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 3.2 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 1.1 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.1 | 5.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 1.0 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 1.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.9 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.3 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.1 | 0.2 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.7 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.9 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.7 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.6 | GO:0001709 | cell fate determination(GO:0001709) |
0.1 | 1.4 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.7 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.4 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.1 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 1.0 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.7 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.9 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.3 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 0.3 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.2 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.3 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 0.4 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.8 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 1.8 | GO:0042430 | indole-containing compound metabolic process(GO:0042430) |
0.1 | 0.4 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.1 | 0.7 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.1 | 0.3 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 1.2 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.1 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.1 | 0.1 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.1 | 0.7 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 8.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.2 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 0.6 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.1 | 0.1 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.1 | 0.1 | GO:0072044 | collecting duct development(GO:0072044) |
0.1 | 0.7 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.9 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.4 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.1 | 0.2 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.1 | 0.2 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.1 | 0.2 | GO:0060594 | mammary gland specification(GO:0060594) |
0.1 | 1.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.4 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.8 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.1 | 0.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.1 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.1 | 0.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.6 | GO:0060425 | lung morphogenesis(GO:0060425) |
0.1 | 0.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.2 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 1.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.3 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 1.6 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.1 | 1.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.7 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.7 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.2 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.1 | 0.1 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.1 | 0.3 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.1 | 0.4 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.4 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.1 | 0.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 2.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.8 | GO:0042133 | neurotransmitter metabolic process(GO:0042133) |
0.1 | 0.3 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 0.1 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.1 | 0.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.3 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.1 | 2.9 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.2 | GO:0051030 | snRNA transport(GO:0051030) |
0.1 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 3.0 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 0.5 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.1 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.1 | 0.6 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 1.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.1 | GO:0050976 | detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
0.1 | 6.2 | GO:0007416 | synapse assembly(GO:0007416) |
0.1 | 0.7 | GO:0086091 | regulation of heart rate by cardiac conduction(GO:0086091) |
0.1 | 2.2 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.2 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.1 | 0.9 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.1 | 0.2 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.1 | 0.2 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 0.1 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.7 | GO:0035640 | exploration behavior(GO:0035640) |
0.1 | 0.2 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) |
0.1 | 0.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 0.6 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
0.1 | 0.6 | GO:0086005 | ventricular cardiac muscle cell action potential(GO:0086005) |
0.1 | 0.2 | GO:1903935 | response to sodium arsenite(GO:1903935) |
0.1 | 1.1 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.4 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 1.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.2 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.1 | 0.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.3 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.3 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.1 | 0.2 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 0.3 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.1 | 0.4 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.1 | GO:0097369 | sodium ion import(GO:0097369) |
0.1 | 0.2 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.0 | 0.6 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 1.2 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.1 | GO:0009397 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.2 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.0 | 0.2 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.0 | 0.1 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.0 | 0.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.4 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.0 | GO:0098964 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
0.0 | 0.5 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.3 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.0 | 0.1 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.0 | 0.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.2 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.0 | 0.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.0 | 0.4 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.2 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.0 | 0.0 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.9 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.2 | GO:0019516 | lactate oxidation(GO:0019516) |
0.0 | 0.3 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.0 | 0.1 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) |
0.0 | 0.2 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.0 | 0.1 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
0.0 | 0.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 1.2 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.5 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.5 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.0 | 0.3 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 3.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.2 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.4 | GO:0042092 | type 2 immune response(GO:0042092) |
0.0 | 0.2 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 0.1 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.0 | 0.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.0 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.2 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.0 | 0.3 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.0 | 0.1 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.0 | 0.1 | GO:0010575 | positive regulation of vascular endothelial growth factor production(GO:0010575) |
0.0 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.0 | 1.2 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.0 | 0.1 | GO:0035660 | MyD88-dependent toll-like receptor 4 signaling pathway(GO:0035660) |
0.0 | 0.1 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.1 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.0 | 0.1 | GO:0048242 | epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
0.0 | 0.4 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.0 | 0.1 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.0 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.2 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.1 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.0 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.4 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.0 | 0.0 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.0 | 0.1 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.0 | 0.1 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.0 | 0.1 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.0 | 0.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.1 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.0 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.0 | 0.2 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.0 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.1 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.0 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.0 | 0.0 | GO:0021546 | rhombomere development(GO:0021546) |
0.0 | 0.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.3 | GO:0030801 | positive regulation of cyclic nucleotide metabolic process(GO:0030801) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.2 | 27.5 | GO:0044317 | rod spherule(GO:0044317) |
3.4 | 27.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
3.1 | 9.4 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
2.9 | 8.8 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
2.7 | 13.7 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
2.2 | 6.6 | GO:0036020 | endolysosome membrane(GO:0036020) |
2.0 | 7.9 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
1.9 | 7.4 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
1.6 | 4.9 | GO:1990630 | IRE1-RACK1-PP2A complex(GO:1990630) |
1.6 | 11.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
1.5 | 7.7 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
1.5 | 1.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.5 | 7.3 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
1.4 | 16.6 | GO:0016011 | dystroglycan complex(GO:0016011) |
1.4 | 5.4 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
1.4 | 5.4 | GO:0097636 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
1.4 | 5.4 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
1.3 | 9.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
1.3 | 23.7 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
1.3 | 3.9 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
1.3 | 23.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.3 | 3.8 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
1.3 | 11.4 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
1.3 | 11.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.2 | 10.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.2 | 8.5 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
1.2 | 18.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
1.2 | 34.9 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
1.2 | 9.3 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
1.2 | 20.7 | GO:0070852 | cell body fiber(GO:0070852) |
1.1 | 3.4 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
1.1 | 18.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
1.1 | 4.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
1.1 | 4.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.1 | 3.2 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
1.1 | 9.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
1.0 | 1.0 | GO:0070449 | elongin complex(GO:0070449) |
1.0 | 4.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.0 | 3.1 | GO:0044753 | amphisome(GO:0044753) |
1.0 | 7.2 | GO:1903349 | omegasome membrane(GO:1903349) |
1.0 | 4.0 | GO:0071942 | XPC complex(GO:0071942) |
1.0 | 3.0 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
0.9 | 3.8 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.9 | 14.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.9 | 2.8 | GO:0014801 | longitudinal sarcoplasmic reticulum(GO:0014801) |
0.9 | 5.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.9 | 3.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.9 | 0.9 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.9 | 7.0 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.9 | 3.5 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.8 | 2.5 | GO:0098855 | HCN channel complex(GO:0098855) |
0.8 | 5.1 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.8 | 4.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.8 | 1.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.8 | 3.3 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.8 | 5.7 | GO:0070695 | FHF complex(GO:0070695) |
0.8 | 8.8 | GO:0043219 | lateral loop(GO:0043219) |
0.8 | 9.0 | GO:0016342 | catenin complex(GO:0016342) |
0.7 | 8.8 | GO:0005915 | zonula adherens(GO:0005915) |
0.7 | 158.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.7 | 3.6 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.7 | 1.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.7 | 8.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.7 | 6.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.7 | 4.0 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.7 | 18.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.6 | 2.6 | GO:1990794 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) |
0.6 | 7.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.6 | 2.5 | GO:0031417 | NatC complex(GO:0031417) |
0.6 | 0.6 | GO:0005914 | spot adherens junction(GO:0005914) |
0.6 | 3.1 | GO:0000802 | transverse filament(GO:0000802) |
0.6 | 3.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.6 | 7.9 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.6 | 3.0 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.6 | 1.2 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.6 | 2.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.6 | 4.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.6 | 2.9 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.6 | 9.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.6 | 2.3 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.6 | 2.8 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.6 | 3.9 | GO:1990246 | uniplex complex(GO:1990246) |
0.6 | 2.2 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.6 | 1.7 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.5 | 1.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.5 | 1.1 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.5 | 2.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.5 | 2.6 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.5 | 28.6 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.5 | 2.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.5 | 2.0 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.5 | 2.5 | GO:0035339 | SPOTS complex(GO:0035339) |
0.5 | 1.5 | GO:0018444 | translation release factor complex(GO:0018444) |
0.5 | 11.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.5 | 1.0 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.5 | 2.9 | GO:0044305 | calyx of Held(GO:0044305) |
0.5 | 7.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.5 | 2.4 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.5 | 1.4 | GO:0098830 | presynaptic endosome(GO:0098830) |
0.5 | 3.3 | GO:0097513 | myosin II filament(GO:0097513) |
0.5 | 2.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.5 | 2.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.5 | 1.4 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.5 | 6.3 | GO:0030663 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) |
0.5 | 3.2 | GO:0097441 | basilar dendrite(GO:0097441) |
0.4 | 2.7 | GO:1990357 | terminal web(GO:1990357) |
0.4 | 4.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.4 | 3.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.4 | 9.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.4 | 2.6 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.4 | 2.1 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
0.4 | 1.3 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.4 | 0.8 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
0.4 | 58.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.4 | 1.3 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.4 | 2.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.4 | 4.4 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.4 | 0.8 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.4 | 1.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 11.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 12.0 | GO:0030057 | desmosome(GO:0030057) |
0.4 | 8.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.4 | 1.5 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.4 | 3.8 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 3.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.4 | 1.5 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.4 | 4.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.4 | 1.5 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 9.1 | GO:0005922 | connexon complex(GO:0005922) |
0.4 | 9.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.4 | 11.3 | GO:0034706 | sodium channel complex(GO:0034706) |
0.4 | 21.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.4 | 0.7 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.4 | 9.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.4 | 1.4 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 8.0 | GO:0033391 | chromatoid body(GO:0033391) |
0.3 | 10.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 3.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 1.4 | GO:0097444 | spine apparatus(GO:0097444) |
0.3 | 2.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.3 | 3.8 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 2.4 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.3 | 0.7 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
0.3 | 3.0 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 8.7 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.3 | 1.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.3 | 15.9 | GO:0035861 | site of double-strand break(GO:0035861) |
0.3 | 0.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.3 | 3.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 6.5 | GO:0035102 | PRC1 complex(GO:0035102) |
0.3 | 5.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.3 | 1.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 0.9 | GO:0060187 | cell pole(GO:0060187) |
0.3 | 5.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 4.0 | GO:0038201 | TOR complex(GO:0038201) |
0.3 | 17.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 0.9 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.3 | 0.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 0.9 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.3 | 3.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 2.6 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.3 | 2.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.3 | 1.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.3 | 8.8 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.3 | 3.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.3 | 1.7 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.3 | 0.8 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.3 | 3.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 3.5 | GO:0036128 | CatSper complex(GO:0036128) |
0.3 | 3.3 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 0.3 | GO:0044299 | C-fiber(GO:0044299) |
0.3 | 1.3 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.3 | 0.8 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.3 | 2.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.3 | 115.3 | GO:0043235 | receptor complex(GO:0043235) |
0.3 | 4.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 1.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.3 | 11.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.3 | 5.1 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 0.8 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.3 | 2.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.3 | 1.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.3 | 2.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 0.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 14.1 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.3 | 1.3 | GO:0000938 | GARP complex(GO:0000938) |
0.3 | 11.3 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 3.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 1.0 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 0.7 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 1.0 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 0.7 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.2 | 1.9 | GO:0044754 | autolysosome(GO:0044754) |
0.2 | 1.4 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 10.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 0.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 1.9 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 5.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 2.5 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 0.7 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.2 | 2.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 4.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 1.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 0.4 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.2 | 2.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 9.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 0.6 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.2 | 0.2 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 11.3 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 0.8 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.2 | 4.0 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 0.8 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 36.9 | GO:0043296 | apical junction complex(GO:0043296) |
0.2 | 23.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 0.6 | GO:0043194 | axon initial segment(GO:0043194) |
0.2 | 1.2 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 1.3 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 0.8 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.2 | 73.8 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 0.6 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.2 | 1.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 5.1 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 0.9 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 1.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 0.5 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.2 | 41.1 | GO:0000139 | Golgi membrane(GO:0000139) |
0.2 | 4.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 3.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 1.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 9.1 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.2 | 19.1 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 0.7 | GO:0035976 | AP1 complex(GO:0035976) |
0.2 | 35.8 | GO:0005740 | mitochondrial envelope(GO:0005740) |
0.2 | 0.5 | GO:0097433 | dense body(GO:0097433) |
0.2 | 0.3 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.2 | 0.8 | GO:0098890 | extrinsic component of postsynaptic membrane(GO:0098890) |
0.2 | 3.8 | GO:0031902 | late endosome membrane(GO:0031902) |
0.2 | 5.1 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.2 | 0.8 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 0.2 | GO:0044301 | climbing fiber(GO:0044301) |
0.2 | 0.8 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 6.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 0.3 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.2 | 6.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 3.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 4.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 0.6 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.2 | 0.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 2.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 2.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 1.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.4 | GO:0036398 | TCR signalosome(GO:0036398) |
0.1 | 1.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.6 | GO:1990037 | Lewy body core(GO:1990037) |
0.1 | 0.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.6 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 1.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 2.6 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.5 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 1.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 1.7 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.6 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 0.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 1.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.4 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 22.2 | GO:0044429 | mitochondrial part(GO:0044429) |
0.1 | 56.7 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.6 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 2.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 140.1 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.8 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 1.9 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.2 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.1 | 0.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 1.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 3.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.2 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.1 | 1.0 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 8.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 2.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 1.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 1.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.3 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 13.8 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 2.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 1.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.4 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 4.8 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.8 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 2.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 37.5 | GO:0005768 | endosome(GO:0005768) |
0.1 | 1.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 1.6 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.4 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.1 | 1.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 4.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.7 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 287.3 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.4 | GO:1990707 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
0.1 | 0.2 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
0.1 | 0.5 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.1 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.3 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.1 | GO:0034657 | GID complex(GO:0034657) |
0.0 | 0.2 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 1.3 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 3.0 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.1 | GO:0070992 | translation initiation complex(GO:0070992) |
0.0 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.9 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 41.9 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.1 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
0.0 | 0.3 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.1 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.0 | 0.1 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.0 | 0.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.6 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.7 | 34.4 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
5.1 | 15.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
5.1 | 15.3 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
5.0 | 15.0 | GO:0008119 | thiopurine S-methyltransferase activity(GO:0008119) |
4.7 | 23.3 | GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
4.6 | 13.8 | GO:0047661 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
4.6 | 13.7 | GO:0046911 | metal chelating activity(GO:0046911) |
4.4 | 13.3 | GO:0004001 | adenosine kinase activity(GO:0004001) |
4.2 | 12.7 | GO:0004454 | ketohexokinase activity(GO:0004454) |
4.2 | 12.6 | GO:0001571 | non-tyrosine kinase fibroblast growth factor receptor activity(GO:0001571) |
4.0 | 20.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
3.9 | 19.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
3.8 | 11.4 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
3.5 | 10.5 | GO:0002061 | uracil binding(GO:0002058) pyrimidine nucleobase binding(GO:0002061) |
3.4 | 13.8 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
3.4 | 10.3 | GO:0016034 | maleylacetoacetate isomerase activity(GO:0016034) |
3.3 | 10.0 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
3.2 | 12.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
3.1 | 15.7 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
3.1 | 9.4 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
3.0 | 15.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
3.0 | 3.0 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
2.7 | 13.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
2.7 | 8.1 | GO:0033971 | hydroxyisourate hydrolase activity(GO:0033971) |
2.7 | 8.0 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
2.6 | 7.8 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
2.5 | 7.6 | GO:0050354 | glycerone kinase activity(GO:0004371) FAD-AMP lyase (cyclizing) activity(GO:0034012) triokinase activity(GO:0050354) |
2.5 | 9.8 | GO:0004103 | choline kinase activity(GO:0004103) |
2.4 | 2.4 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
2.4 | 9.8 | GO:0050632 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
2.4 | 9.7 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
2.4 | 7.2 | GO:0008396 | oxysterol 7-alpha-hydroxylase activity(GO:0008396) |
2.4 | 9.6 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
2.4 | 14.1 | GO:0004359 | glutaminase activity(GO:0004359) |
2.3 | 9.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
2.3 | 18.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
2.2 | 13.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
2.2 | 6.6 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
2.2 | 8.8 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
2.1 | 15.0 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
2.1 | 12.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
2.1 | 6.4 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
2.1 | 16.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
2.1 | 6.2 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
2.0 | 8.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
2.0 | 5.9 | GO:0015292 | uniporter activity(GO:0015292) |
1.9 | 11.4 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
1.9 | 7.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.9 | 7.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.9 | 5.6 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.9 | 7.4 | GO:0005118 | sevenless binding(GO:0005118) |
1.9 | 1.9 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.8 | 11.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
1.8 | 18.3 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.8 | 20.0 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
1.8 | 9.1 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
1.8 | 1.8 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
1.8 | 9.0 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
1.8 | 12.4 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.8 | 5.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.8 | 8.8 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
1.7 | 5.2 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
1.7 | 10.4 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
1.7 | 8.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.7 | 6.7 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.7 | 6.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.7 | 8.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.6 | 11.2 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
1.6 | 12.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
1.6 | 4.8 | GO:0004493 | methylmalonyl-CoA epimerase activity(GO:0004493) |
1.6 | 9.4 | GO:0032810 | sterol response element binding(GO:0032810) |
1.6 | 4.7 | GO:0005368 | beta-alanine transmembrane transporter activity(GO:0001761) taurine transmembrane transporter activity(GO:0005368) taurine:sodium symporter activity(GO:0005369) |
1.6 | 6.3 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
1.5 | 6.2 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
1.5 | 6.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.5 | 4.6 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
1.5 | 4.6 | GO:0070279 | vitamin B6 binding(GO:0070279) |
1.5 | 4.6 | GO:0015152 | glucose-6-phosphate transmembrane transporter activity(GO:0015152) |
1.5 | 10.8 | GO:0097016 | L27 domain binding(GO:0097016) |
1.5 | 13.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.5 | 4.4 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
1.4 | 14.4 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
1.4 | 1.4 | GO:0016151 | nickel cation binding(GO:0016151) |
1.4 | 5.7 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
1.4 | 7.0 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.4 | 5.4 | GO:0042806 | fucose binding(GO:0042806) |
1.3 | 16.2 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.3 | 17.0 | GO:0039706 | co-receptor binding(GO:0039706) |
1.3 | 5.2 | GO:0004096 | catalase activity(GO:0004096) |
1.3 | 3.9 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
1.3 | 3.8 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
1.3 | 5.0 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
1.3 | 7.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.3 | 3.8 | GO:0004067 | asparaginase activity(GO:0004067) |
1.2 | 3.7 | GO:0010428 | methyl-CpNpG binding(GO:0010428) |
1.2 | 3.7 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
1.2 | 3.6 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
1.2 | 10.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
1.2 | 3.6 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) |
1.2 | 8.3 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
1.2 | 3.5 | GO:0034632 | retinol transporter activity(GO:0034632) |
1.2 | 3.5 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
1.2 | 1.2 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
1.2 | 11.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.1 | 8.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.1 | 4.6 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
1.1 | 3.4 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
1.1 | 4.6 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
1.1 | 1.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
1.1 | 5.7 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
1.1 | 7.9 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
1.1 | 4.5 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.1 | 30.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.1 | 3.3 | GO:0003868 | 4-hydroxyphenylpyruvate dioxygenase activity(GO:0003868) |
1.1 | 5.5 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
1.1 | 3.2 | GO:0005289 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
1.0 | 4.1 | GO:0070404 | NADH binding(GO:0070404) |
1.0 | 11.3 | GO:0031419 | cobalamin binding(GO:0031419) |
1.0 | 6.1 | GO:0008142 | oxysterol binding(GO:0008142) |
1.0 | 2.0 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
1.0 | 2.0 | GO:0019970 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
1.0 | 14.9 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
1.0 | 7.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.0 | 4.0 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
1.0 | 7.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.0 | 2.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
1.0 | 4.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
1.0 | 4.9 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.0 | 2.9 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
1.0 | 4.9 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
1.0 | 2.9 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
1.0 | 1.9 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.0 | 2.9 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
1.0 | 6.7 | GO:0019213 | deacetylase activity(GO:0019213) |
1.0 | 11.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
1.0 | 5.7 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
1.0 | 1.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
1.0 | 2.9 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.9 | 2.8 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.9 | 11.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.9 | 2.7 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.9 | 2.7 | GO:0047936 | glucose 1-dehydrogenase [NAD(P)] activity(GO:0047936) |
0.9 | 5.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.9 | 11.5 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.9 | 2.6 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.9 | 2.6 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.9 | 16.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.9 | 2.6 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.8 | 9.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.8 | 4.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.8 | 2.5 | GO:0001566 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
0.8 | 3.4 | GO:0047726 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.8 | 4.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.8 | 3.3 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.8 | 12.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.8 | 2.5 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.8 | 1.6 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.8 | 4.9 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.8 | 1.6 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.8 | 5.6 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.8 | 8.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.8 | 1.6 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.8 | 3.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.8 | 0.8 | GO:0016885 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.8 | 2.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.8 | 4.7 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.8 | 2.3 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.8 | 8.6 | GO:0035473 | lipase binding(GO:0035473) |
0.8 | 5.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.8 | 1.6 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.8 | 2.3 | GO:0050421 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitric oxide binding(GO:0070026) |
0.8 | 3.1 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.8 | 2.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.8 | 0.8 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.8 | 2.3 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
0.8 | 2.3 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.8 | 3.8 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.8 | 1.5 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.8 | 3.8 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.7 | 12.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.7 | 1.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.7 | 2.9 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.7 | 3.6 | GO:0015923 | mannosidase activity(GO:0015923) |
0.7 | 15.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.7 | 6.4 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.7 | 4.2 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.7 | 4.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.7 | 4.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.7 | 11.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.7 | 6.3 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) |
0.7 | 5.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.7 | 4.9 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.7 | 2.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.7 | 1.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.7 | 2.8 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.7 | 2.7 | GO:0004063 | aryldialkylphosphatase activity(GO:0004063) |
0.7 | 2.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.7 | 2.0 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.7 | 4.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.7 | 2.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.7 | 2.7 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.7 | 2.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.7 | 2.0 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.7 | 2.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.7 | 2.7 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.7 | 3.3 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.6 | 6.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.6 | 2.6 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.6 | 4.5 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.6 | 10.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.6 | 2.6 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.6 | 10.1 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.6 | 1.9 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.6 | 3.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.6 | 1.9 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
0.6 | 6.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.6 | 5.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.6 | 14.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.6 | 0.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.6 | 5.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.6 | 2.4 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
0.6 | 2.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.6 | 5.3 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.6 | 2.3 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.6 | 5.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.6 | 9.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.6 | 4.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.6 | 0.6 | GO:0035671 | enone reductase activity(GO:0035671) |
0.6 | 14.3 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.6 | 12.5 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.6 | 10.8 | GO:0090079 | translation repressor activity, nucleic acid binding(GO:0000900) translation regulator activity, nucleic acid binding(GO:0090079) |
0.6 | 5.1 | GO:0071253 | connexin binding(GO:0071253) |
0.6 | 11.8 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.6 | 6.7 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.5 | 3.8 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.5 | 1.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.5 | 8.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.5 | 2.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.5 | 3.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.5 | 3.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.5 | 1.6 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.5 | 1.6 | GO:0016213 | linoleoyl-CoA desaturase activity(GO:0016213) |
0.5 | 6.4 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.5 | 4.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.5 | 2.7 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.5 | 25.7 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.5 | 5.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.5 | 5.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.5 | 2.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.5 | 3.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.5 | 1.5 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
0.5 | 2.1 | GO:0030984 | kininogen binding(GO:0030984) |
0.5 | 1.5 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.5 | 1.5 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.5 | 8.2 | GO:0030371 | translation repressor activity(GO:0030371) |
0.5 | 1.5 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.5 | 3.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.5 | 2.5 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.5 | 1.5 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.5 | 6.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.5 | 1.5 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.5 | 4.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.5 | 4.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.5 | 3.9 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.5 | 3.9 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.5 | 1.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.5 | 2.4 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.5 | 1.9 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.5 | 1.9 | GO:0035276 | ethanol binding(GO:0035276) |
0.5 | 4.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.5 | 0.9 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.5 | 0.9 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.5 | 5.1 | GO:0046977 | TAP binding(GO:0046977) |
0.5 | 1.4 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.5 | 6.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 0.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.5 | 20.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.5 | 1.8 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.4 | 9.9 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.4 | 5.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 1.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.4 | 3.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.4 | 24.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.4 | 1.3 | GO:0035939 | microsatellite binding(GO:0035939) |
0.4 | 2.2 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.4 | 4.4 | GO:0032052 | bile acid binding(GO:0032052) |
0.4 | 4.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 3.0 | GO:0089720 | caspase binding(GO:0089720) |
0.4 | 2.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.4 | 7.4 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.4 | 0.9 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
0.4 | 5.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.4 | 3.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.4 | 6.4 | GO:0043495 | protein anchor(GO:0043495) |
0.4 | 1.3 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.4 | 3.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 2.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.4 | 3.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.4 | 1.7 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.4 | 2.9 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.4 | 0.8 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.4 | 1.2 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
0.4 | 1.2 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.4 | 4.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.4 | 1.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.4 | 2.1 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.4 | 4.1 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 4.9 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.4 | 4.9 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.4 | 2.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.4 | 4.8 | GO:0008430 | selenium binding(GO:0008430) |
0.4 | 6.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.4 | 1.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.4 | 2.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.4 | 2.8 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.4 | 1.2 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.4 | 3.9 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.4 | 1.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.4 | 1.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.4 | 6.6 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
0.4 | 2.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.4 | 4.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 3.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.4 | 3.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.4 | 4.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.4 | 2.3 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.4 | 1.5 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.4 | 22.8 | GO:0015485 | cholesterol binding(GO:0015485) |
0.4 | 12.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.4 | 1.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.4 | 0.7 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.4 | 2.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.4 | 5.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.4 | 21.9 | GO:0005496 | steroid binding(GO:0005496) |
0.4 | 5.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.4 | 1.5 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.4 | 1.8 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.4 | 1.4 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.4 | 1.4 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.4 | 0.7 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.4 | 6.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.4 | 1.4 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.4 | 7.2 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.4 | 2.5 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.4 | 7.1 | GO:0001848 | complement binding(GO:0001848) |
0.4 | 1.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.4 | 5.0 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.3 | 5.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 1.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.3 | 1.4 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.3 | 0.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 2.0 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 10.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 1.0 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
0.3 | 1.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 3.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 2.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 1.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 3.7 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 2.3 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.3 | 2.0 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.3 | 2.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 1.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.3 | 1.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 1.3 | GO:0019862 | IgA binding(GO:0019862) |
0.3 | 1.3 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
0.3 | 1.3 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
0.3 | 1.0 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.3 | 1.3 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.3 | 0.3 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.3 | 0.9 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 4.9 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.3 | 0.9 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.3 | 2.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 1.8 | GO:0071814 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.3 | 4.9 | GO:0016595 | glutamate binding(GO:0016595) |
0.3 | 3.9 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.3 | 6.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 2.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 4.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.3 | 1.2 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.3 | 12.4 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.3 | 10.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.3 | 1.2 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
0.3 | 0.9 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.3 | 2.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 4.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 1.2 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.3 | 0.9 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.3 | 0.9 | GO:0019002 | GMP binding(GO:0019002) |
0.3 | 1.4 | GO:0030060 | malate dehydrogenase activity(GO:0016615) L-malate dehydrogenase activity(GO:0030060) |
0.3 | 14.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.3 | 0.8 | GO:0004133 | glycogen debranching enzyme activity(GO:0004133) 4-alpha-glucanotransferase activity(GO:0004134) amylo-alpha-1,6-glucosidase activity(GO:0004135) |
0.3 | 1.7 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.3 | 1.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.3 | 1.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 1.9 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.3 | 9.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.3 | 1.1 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.3 | 4.2 | GO:0046030 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.3 | 1.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.3 | 1.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.3 | 1.6 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.3 | 2.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 1.0 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.3 | 0.8 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.3 | 1.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.3 | 20.8 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.3 | 8.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 2.8 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.3 | 0.8 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.3 | 1.5 | GO:0015491 | cation:cation antiporter activity(GO:0015491) |
0.3 | 3.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 3.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 1.0 | GO:0036478 | tyrosine 3-monooxygenase activator activity(GO:0036470) L-dopa decarboxylase activator activity(GO:0036478) |
0.2 | 2.0 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 2.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 10.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 4.5 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.2 | 1.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 5.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 5.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 1.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.2 | 2.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 1.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 3.1 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 3.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 3.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 4.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 0.7 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 1.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 8.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 1.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 3.4 | GO:0071949 | FAD binding(GO:0071949) |
0.2 | 0.9 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 2.9 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 0.5 | GO:0043559 | insulin binding(GO:0043559) |
0.2 | 1.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 9.2 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.2 | 0.9 | GO:0034597 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.2 | 1.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 31.7 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.2 | 5.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 0.7 | GO:0016807 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
0.2 | 0.2 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.2 | 0.9 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.2 | 3.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 3.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 0.7 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.2 | 3.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.2 | 0.9 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 0.6 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.2 | 1.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.6 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 0.6 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.2 | 1.3 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.2 | 0.8 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
0.2 | 9.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 1.8 | GO:0016594 | glycine binding(GO:0016594) |
0.2 | 3.7 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.2 | 1.8 | GO:0005234 | ionotropic glutamate receptor activity(GO:0004970) extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.2 | 3.6 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 0.6 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.2 | 0.8 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.2 | 4.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 2.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 1.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 1.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 1.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.6 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.2 | 1.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 5.0 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.6 | GO:0045030 | UTP-activated nucleotide receptor activity(GO:0045030) |
0.2 | 0.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 0.6 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.2 | 5.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 0.7 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 4.6 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 1.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 1.8 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 1.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 0.9 | GO:0019962 | interferon receptor activity(GO:0004904) type I interferon receptor activity(GO:0004905) type I interferon binding(GO:0019962) |
0.2 | 1.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 1.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 0.9 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 0.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 1.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.2 | 2.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 2.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 2.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 1.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.2 | 0.3 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.2 | 6.2 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.2 | 2.8 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 3.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.5 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 2.3 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 0.8 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 0.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.2 | 1.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 6.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 0.5 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.2 | 1.0 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.2 | 19.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 6.1 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 1.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.2 | 0.6 | GO:0051435 | BH4 domain binding(GO:0051435) |
0.2 | 1.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 3.2 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.2 | 0.8 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.2 | 0.3 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 2.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 0.8 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 1.1 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.2 | 0.6 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.1 | 3.4 | GO:0009975 | cyclase activity(GO:0009975) |
0.1 | 6.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 5.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 1.8 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 2.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.4 | GO:0070773 | protein-N-terminal glutamine amidohydrolase activity(GO:0070773) |
0.1 | 0.6 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 2.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.4 | GO:0052594 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.1 | 0.6 | GO:0047874 | dolichyldiphosphatase activity(GO:0047874) |
0.1 | 0.6 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 1.5 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.8 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.4 | GO:0031753 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
0.1 | 1.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.5 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 1.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 3.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 4.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 1.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 4.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 2.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 7.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 1.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.6 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 1.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.2 | GO:0008158 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) |
0.1 | 2.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 1.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.6 | GO:0102344 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 6.5 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 0.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 11.0 | GO:0015108 | chloride transmembrane transporter activity(GO:0015108) |
0.1 | 2.7 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 1.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.7 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 1.0 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 2.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 3.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.2 | GO:0099530 | PLC activating G-protein coupled glutamate receptor activity(GO:0001639) G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) |
0.1 | 8.3 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 4.0 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.1 | 3.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 4.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 1.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 3.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.3 | GO:1990931 | oxidative DNA demethylase activity(GO:0035516) RNA N6-methyladenosine dioxygenase activity(GO:1990931) |
0.1 | 0.1 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
0.1 | 0.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 1.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 2.5 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.4 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 3.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 2.6 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.1 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.5 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 4.0 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 5.8 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.3 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 37.1 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 2.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.4 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.3 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.1 | 0.3 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.1 | 8.8 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.6 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 1.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 11.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 8.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.5 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.1 | 2.4 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.1 | 0.2 | GO:0052692 | raffinose alpha-galactosidase activity(GO:0052692) |
0.1 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.1 | GO:0015296 | anion:cation symporter activity(GO:0015296) |
0.1 | 2.6 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 7.1 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 0.2 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.1 | 0.4 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.3 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 12.4 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 2.4 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 1.4 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 1.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.3 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 1.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.4 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.6 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.1 | 2.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 11.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 1.2 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.1 | 0.1 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
0.1 | 0.3 | GO:0019778 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.1 | 0.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.2 | GO:0016492 | G-protein coupled neurotensin receptor activity(GO:0016492) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.6 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 1.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 1.7 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 0.5 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 6.4 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 0.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 1.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.7 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.2 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 3.4 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 0.3 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 1.0 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 2.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.4 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.1 | 0.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.7 | GO:1905030 | voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.1 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.0 | 0.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.0 | 0.1 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
0.0 | 0.6 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.3 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 0.2 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.2 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.0 | 0.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.0 | 0.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.7 | GO:0019842 | vitamin binding(GO:0019842) |
0.0 | 0.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.1 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.0 | 0.1 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.1 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.0 | 0.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.1 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.3 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.5 | GO:0015103 | inorganic anion transmembrane transporter activity(GO:0015103) |
0.0 | 1.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.1 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.0 | 0.2 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 0.3 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.0 | 0.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.5 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.3 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 0.3 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.0 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.1 | GO:0051381 | histamine binding(GO:0051381) |
0.0 | 0.3 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.4 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.0 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.1 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.0 | 1.5 | GO:0005125 | cytokine activity(GO:0005125) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 2.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.8 | 16.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.8 | 1.8 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
1.0 | 31.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.9 | 2.7 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.8 | 46.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.7 | 13.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.6 | 22.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.6 | 5.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.6 | 22.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.5 | 13.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.5 | 11.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.5 | 17.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.5 | 30.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.5 | 18.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.5 | 5.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.5 | 31.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.5 | 9.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.4 | 1.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 1.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.4 | 25.0 | PID BMP PATHWAY | BMP receptor signaling |
0.4 | 13.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.4 | 9.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 5.8 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 11.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.4 | 13.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.4 | 7.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 1.7 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.3 | 7.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.3 | 8.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.3 | 2.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 6.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 8.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 1.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.3 | 1.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 2.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.3 | 0.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 2.5 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 6.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 7.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 5.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 3.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 1.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 10.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 9.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 1.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 0.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 2.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 1.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 30.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 0.8 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.2 | 3.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 1.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 3.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 2.5 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 8.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 7.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 35.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 4.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 2.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 23.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 6.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 2.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 3.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 1.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 3.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 1.2 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 2.5 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 3.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 3.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 1.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 4.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 1.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 2.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 10.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
2.1 | 8.5 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
1.9 | 46.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.8 | 53.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.6 | 40.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
1.3 | 14.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.3 | 5.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.2 | 2.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
1.1 | 43.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
1.1 | 6.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
1.1 | 22.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
1.0 | 34.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
1.0 | 22.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
1.0 | 2.0 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
1.0 | 5.9 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.9 | 32.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.9 | 30.9 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.9 | 15.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.9 | 9.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.9 | 12.0 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.8 | 16.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.8 | 3.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.8 | 3.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.8 | 23.7 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.8 | 10.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.8 | 3.1 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.8 | 2.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.8 | 16.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.7 | 2.9 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.7 | 15.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.7 | 6.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.7 | 12.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.7 | 1.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.6 | 59.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.6 | 7.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.6 | 10.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.6 | 0.6 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.6 | 1.2 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.6 | 13.3 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.6 | 9.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.6 | 11.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.6 | 11.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.6 | 22.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.5 | 2.7 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.5 | 14.3 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.5 | 20.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.5 | 6.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.5 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.5 | 1.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.5 | 6.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.5 | 14.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.5 | 3.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.5 | 9.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.5 | 14.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.5 | 5.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.5 | 8.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.5 | 14.6 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.5 | 24.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.4 | 0.4 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.4 | 6.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.4 | 13.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.4 | 8.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.4 | 9.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.4 | 8.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.4 | 2.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.4 | 5.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.4 | 1.7 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.4 | 0.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.4 | 2.0 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.4 | 8.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.4 | 6.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.4 | 8.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 2.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.4 | 11.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.4 | 4.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.4 | 6.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 9.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 24.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.4 | 7.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.4 | 9.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 22.8 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.3 | 8.0 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.3 | 4.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 0.3 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.3 | 1.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.3 | 4.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 0.9 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 3.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 0.3 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.3 | 3.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 15.8 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.3 | 0.9 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.3 | 4.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.3 | 2.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.3 | 3.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 15.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 4.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 1.7 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.3 | 9.9 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.3 | 43.5 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.3 | 11.6 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.3 | 5.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 6.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 4.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 17.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.2 | 1.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 2.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.2 | 5.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 4.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 7.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 3.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 8.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 0.2 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.2 | 2.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 0.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 0.4 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.2 | 11.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 21.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 7.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 2.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 1.5 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 3.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 2.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.4 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.1 | 0.4 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.1 | 2.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 2.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.9 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 2.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 2.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 2.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 2.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 3.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 3.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 0.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 7.0 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 1.8 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.1 | 4.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 2.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 2.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 3.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.9 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 1.0 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 0.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 1.1 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 2.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 1.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 1.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 1.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 1.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 0.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.1 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |